<full-text-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/article/dtd" xmlns:bk="http://www.elsevier.com/xml/bk/dtd" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/article/pii/S0223523415302373</prism:url><dc:identifier>doi:10.1016/j.ejmech.2015.08.054</dc:identifier><eid>1-s2.0-S0223523415302373</eid><prism:doi>10.1016/j.ejmech.2015.08.054</prism:doi><pii>S0223-5234(15)30237-3</pii><dc:title>Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors </dc:title><prism:publicationName>European Journal of Medicinal Chemistry</prism:publicationname><prism:aggregationType>Journal</prism:aggregationtype><pubType>fla</pubtype><prism:issn>02235234</prism:issn><prism:volume>103</prism:volume><prism:startingPage>163</prism:startingpage><prism:endingPage>174</prism:endingpage><prism:pageRange>163-174</prism:pagerange><dc:format>text/xml</dc:format><prism:coverDate>2015-10-20</prism:coverdate><prism:coverDisplayDate>20 October 2015</prism:coverdisplaydate><prism:copyright>Copyright © 2015 Elsevier Masson SAS. All rights reserved.</prism:copyright><prism:publisher>Elsevier Masson SAS.</prism:publisher><dc:creator>Pallandre, Jean-René</dc:creator><dc:creator>Borg, Christophe</dc:creator><dc:creator>Rognan, Didier</dc:creator><dc:creator>Boibessot, Thibault</dc:creator><dc:creator>Luzet, Vincent</dc:creator><dc:creator>Yesylevskyy, Semen</dc:creator><dc:creator>Ramseyer, Christophe</dc:creator><dc:creator>Pudlo, Marc</dc:creator><dc:description>
                  The development of inhibitors blocking STAT3 transcriptional activity is a promising therapeutic approach against cancer and inflammatory diseases. In this context, the selectivity of inhibitors against the STAT1 transcription factor is crucial as STAT3 and STAT1 play opposite roles in the apoptosis of tumor cells and polarization of the immune response. A structure-based virtual screening followed by a luciferase-containing promoter assay on STAT3 and STAT1 signaling were used to identify a selective STAT3 inhibitor. An important role of the aminotetrazole group in modulating STAT3 and STAT1 inhibitory activities has been established. Optimization of the hit compound leads to 23. This compound inhibits growth and survival of cells with STAT3 signaling pathway while displaying a minimal effect on STAT1 signaling. Moreover, it prevents lymphocyte T polarization into Th17 and Treg without affecting their differentiation into Th1 lymphocyte.
               </dc:description><openaccess>0</openaccess><openaccessArticle>false</openaccessarticle><openaccessType/></openaccesstype><openArchiveArticle>false</openarchivearticle><openaccessSponsorName/></openaccesssponsorname><openaccessSponsorType/></openaccesssponsortype><openaccessUserLicense/></openaccessuserlicense><dcterms:subject>STAT3</dcterms:subject><dcterms:subject>Small-molecule inhibitor</dcterms:subject><dcterms:subject>Aminotetrazole</dcterms:subject><dcterms:subject>Anticancer drug</dcterms:subject><dcterms:subject>Inflammation</dcterms:subject><link href="https://api.elsevier.com/content/article/pii/S0223523415302373" rel="self"/></link><link href="https://www.sciencedirect.com/science/article/pii/S0223523415302373" rel="scidir"/></link></coredata><objects><object ref="fx1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="57" size="8850">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-fx1.sml?httpAccept=%2A%2F%2A</object><object ref="fx2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="120" height="164" size="13715">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-fx2.sml?httpAccept=%2A%2F%2A</object><object ref="gr1" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="119" height="164" size="18321">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr1.sml?httpAccept=%2A%2F%2A</object><object ref="gr2" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="89" size="16901">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr2.sml?httpAccept=%2A%2F%2A</object><object ref="gr3" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="33" size="6335">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr3.sml?httpAccept=%2A%2F%2A</object><object ref="gr4" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="142" height="163" size="17835">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr4.sml?httpAccept=%2A%2F%2A</object><object ref="gr5" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="129" size="13787">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr5.sml?httpAccept=%2A%2F%2A</object><object ref="gr6" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="94" height="163" size="15071">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr6.sml?httpAccept=%2A%2F%2A</object><object ref="gr7" category="thumbnail" type="IMAGE-THUMBNAIL" multimediatype="GIF image file" mimetype="image/gif" width="219" height="120" size="15737">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr7.sml?httpAccept=%2A%2F%2A</object><object ref="fx1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="500" height="129" size="38264">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-fx1.jpg?httpAccept=%2A%2F%2A</object><object ref="fx2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="734" height="1002" size="207971">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-fx2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr1" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="535" height="738" size="113023">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr1.jpg?httpAccept=%2A%2F%2A</object><object ref="gr2" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="578" height="234" size="66464">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr2.jpg?httpAccept=%2A%2F%2A</object><object ref="gr3" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="734" height="112" size="23892">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr3.jpg?httpAccept=%2A%2F%2A</object><object ref="gr4" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="388" height="447" size="78927">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr4.jpg?httpAccept=%2A%2F%2A</object><object ref="gr5" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="535" height="316" size="53507">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr5.jpg?httpAccept=%2A%2F%2A</object><object ref="gr6" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="580" height="1007" size="126028">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr6.jpg?httpAccept=%2A%2F%2A</object><object ref="gr7" category="standard" type="IMAGE-DOWNSAMPLED" multimediatype="JPEG image file" mimetype="image/jpeg" width="711" height="390" size="80855">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-gr7.jpg?httpAccept=%2A%2F%2A</object><object ref="mmc1" category="standard" type="APPLICATION" multimediatype="Microsoft Word file" mimetype="application/word" size="12992000">https://api.elsevier.com/content/object/eid/1-s2.0-S0223523415302373-mmc1.doc?httpAccept=%2A%2F%2A</object></objects><scopus-id>84941285460</scopus-id><scopus-eid>2-s2.0-84941285460</scopus-eid><pubmed-id>26352675</pubmed-id><link href="https://api.elsevier.com/content/abstract/scopus_id/84941285460" rel="abstract"/></link><originalText><xocs:doc xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <xocs:content-family>serial</xocs:content-family>
      <xocs:content-type>JL</xocs:content-type>
      <xocs:cid>271932</xocs:cid>
      <xocs:ssids>
         <xocs:ssid type="alllist">291210</xocs:ssid>
         <xocs:ssid type="subj">291732</xocs:ssid>
         <xocs:ssid type="subj">291789</xocs:ssid>
         <xocs:ssid type="subj">291858</xocs:ssid>
         <xocs:ssid type="subj">291928</xocs:ssid>
         <xocs:ssid type="content">31</xocs:ssid>
      </xocs:ssids>
      <xocs:srctitle>European Journal of Medicinal Chemistry</xocs:srctitle>
      <xocs:normalized-srctitle>EUROPEANJOURNALMEDICINALCHEMISTRY</xocs:normalized-srctitle>
      <xocs:orig-load-date yyyymmdd="20150901">2015-09-01</xocs:orig-load-date>
      <xocs:available-online-date yyyymmdd="20150901">2015-09-01</xocs:available-online-date>
      <xocs:vor-load-date yyyymmdd="20150906">2015-09-06</xocs:vor-load-date>
      <xocs:vor-available-online-date yyyymmdd="20150906">2015-09-06</xocs:vor-available-online-date>
      <xocs:ew-transaction-id>2016-02-22T09:10:13</xocs:ew-transaction-id>
      <xocs:eid>1-s2.0-S0223523415302373</xocs:eid>
      <xocs:pii-formatted>S0223-5234(15)30237-3</xocs:pii-formatted>
      <xocs:pii-unformatted>S0223523415302373</xocs:pii-unformatted>
      <xocs:doi>10.1016/j.ejmech.2015.08.054</xocs:doi>
      <xocs:item-stage>S300</xocs:item-stage>
      <xocs:item-version-number>S300.3</xocs:item-version-number>
      <xocs:item-weight>FULL-TEXT</xocs:item-weight>
      <xocs:hub-eid>1-s2.0-S0223523415X00122</xocs:hub-eid>
      <xocs:timestamp yyyymmdd="20160902">2016-09-02T12:55:22.661072-04:00</xocs:timestamp>
      <xocs:dco>0</xocs:dco>
      <xocs:tomb>0</xocs:tomb>
      <xocs:date-search-begin>20151020</xocs:date-search-begin>
      <xocs:year-nav>2015</xocs:year-nav>
      <xocs:indexeddate epoch="1441134512">2015-09-01T19:08:32.175633Z</xocs:indexeddate>
      <xocs:articleinfo>absattachment articleinfo articletitlenorm authfirstinitialnorm authfirstsurnamenorm cid cids contenttype copyright crossmark dateloaded dateloadedtxt datesearch datesort dateupdated dco docsubtype doctype doi eid ewtransactionid hubeid indexeddate issn issnnorm itemstage itemtransactionid itemweight openaccess openarchive pg pgfirst pglast pii piinorm pubdatestart pubdatetxt pubyr sectiontitle sortorder srctitle srctitlenorm srctype ssids alllist content subj subheadings suppl tomb volfirst volissue volumelist webpdf webpdfpagecount yearnav figure table e-component body acknowledge affil appendices articletitle auth authfirstini authfull authkeywords authlast grantnumber grantsponsor highlightsabst orcid otherkwds primabst pubtype ref specialabst</xocs:articleinfo>
      <xocs:issns>
         <xocs:issn-primary-formatted>0223-5234</xocs:issn-primary-formatted>
         <xocs:issn-primary-unformatted>02235234</xocs:issn-primary-unformatted>
      </xocs:issns>
      <xocs:crossmark is-crossmark="1">true</xocs:crossmark>
      <xocs:vol-first>103</xocs:vol-first>
      <xocs:volume-list>
         <xocs:volume>103</xocs:volume>
      </xocs:volume-list>
      <xocs:suppl>C</xocs:suppl>
      <xocs:vol-iss-suppl-text>Volume 103</xocs:vol-iss-suppl-text>
      <xocs:sort-order>13</xocs:sort-order>
      <xocs:first-fp>163</xocs:first-fp>
      <xocs:last-lp>174</xocs:last-lp>
      <xocs:pages>
         <xocs:first-page>163</xocs:first-page>
         <xocs:last-page>174</xocs:last-page>
      </xocs:pages>
      <xocs:cover-date-orig>
         <xocs:start-date>20151020</xocs:start-date>
      </xocs:cover-date-orig>
      <xocs:cover-date-text>20 October 2015</xocs:cover-date-text>
      <xocs:cover-date-start>2015-10-20</xocs:cover-date-start>
      <xocs:cover-date-year>2015</xocs:cover-date-year>
      <xocs:hub-sec>
         <xocs:hub-sec-title>Original articles</xocs:hub-sec-title>
      </xocs:hub-sec>
      <xocs:document-type>article</xocs:document-type>
      <xocs:document-subtype>fla</xocs:document-subtype>
      <xocs:copyright-line>Copyright © 2015 Elsevier Masson SAS. All rights reserved.</xocs:copyright-line>
      <xocs:normalized-article-title>NOVELAMINOTETRAZOLEDERIVATIVESSELECTIVESTAT3NONPEPTIDEINHIBITORS</xocs:normalized-article-title>
      <xocs:normalized-first-auth-surname>PALLANDRE</xocs:normalized-first-auth-surname>
      <xocs:normalized-first-auth-initial>J</xocs:normalized-first-auth-initial>
      <xocs:item-toc>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>1</xocs:item-toc-label>
            <xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>2</xocs:item-toc-label>
            <xocs:item-toc-section-title>Results</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Virtual screening for non-peptide inhibitors of STAT3 SH2 domain</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>Influence of the selected STAT3 inhibitors on STAT1 activity</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Structure-activity relationships and development of inhibitor 23</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.4</xocs:item-toc-label>
               <xocs:item-toc-section-title>Importance of the aminotetrazole group</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>2.5</xocs:item-toc-label>
               <xocs:item-toc-section-title>Biological assessment of compound 23</xocs:item-toc-section-title>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>3</xocs:item-toc-label>
            <xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:sections">
            <xocs:item-toc-label>4</xocs:item-toc-label>
            <xocs:item-toc-section-title>Experimental section</xocs:item-toc-section-title>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.1</xocs:item-toc-label>
               <xocs:item-toc-section-title>Computational chemistry</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Screening compounds collection</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Virtual screening</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.1.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Molecular dynamics simulations and ensemble docking</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.2</xocs:item-toc-label>
               <xocs:item-toc-section-title>STAT inhibitors synthesis</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-chloro-5-methoxy-4-(4-methylbenzyloxy)benzaldehyde 42</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>N-(3-chloro-5-methoxy-4-(4-methylbenzyloxy)benzyl)-2H-tetrazole-5-amine 5</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>3-chloro-5-methoxy-4-(4-nitrobenzyloxy)benzaldehyde 46</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.2.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>N-(3-chloro-5-methoxy-4-(4-nitrobenzyloxy)benzyl)-2H-tetrazole-5-amine 23</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
            <xocs:item-toc-entry ref-elem="ce:sections">
               <xocs:item-toc-label>4.3</xocs:item-toc-label>
               <xocs:item-toc-section-title>Biological assays</xocs:item-toc-section-title>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.1</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Cells and reagents</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.2</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Generation of reporter cell lines</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.3</xocs:item-toc-label>
                  <xocs:item-toc-section-title>STAT promoter assays</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.4</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Fluorescence polarization assay</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.5</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Western blotting</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.6</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Confocal microscopy</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.7</xocs:item-toc-label>
                  <xocs:item-toc-section-title>In vitro differentiation of T cells</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.8</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Real-time quantitative PCR</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.9</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Cell line proliferation assays</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
               <xocs:item-toc-entry ref-elem="ce:sections">
                  <xocs:item-toc-label>4.3.10</xocs:item-toc-label>
                  <xocs:item-toc-section-title>Assessment of cytokine production</xocs:item-toc-section-title>
               </xocs:item-toc-entry>
            </xocs:item-toc-entry>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:acknowledgment">
            <xocs:item-toc-section-title>Acknowledgment</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:appendices">
            <xocs:item-toc-label>Appendix A</xocs:item-toc-label>
            <xocs:item-toc-section-title>Supplementary data</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
         <xocs:item-toc-entry ref-elem="ce:bibliography">
            <xocs:item-toc-section-title>References</xocs:item-toc-section-title>
         </xocs:item-toc-entry>
      </xocs:item-toc>
      <xocs:references>
         <xocs:ref-info refid="bib1a">
            <xocs:ref-normalized-surname>DARNELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>740</xocs:ref-first-fp>
            <xocs:ref-last-lp>749</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib1b">
            <xocs:ref-normalized-surname>DARNELL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1997</xocs:ref-pub-year>
            <xocs:ref-first-fp>1630</xocs:ref-first-fp>
            <xocs:ref-last-lp>1635</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib2a">
            <xocs:ref-normalized-surname>GREENLUND</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1994</xocs:ref-pub-year>
            <xocs:ref-first-fp>1591</xocs:ref-first-fp>
            <xocs:ref-last-lp>1600</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib2b">
            <xocs:ref-normalized-surname>SHUAI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1993</xocs:ref-pub-year>
            <xocs:ref-first-fp>1744</xocs:ref-first-fp>
            <xocs:ref-last-lp>1746</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib3a">
            <xocs:ref-normalized-surname>IHLE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1996</xocs:ref-pub-year>
            <xocs:ref-first-fp>331</xocs:ref-first-fp>
            <xocs:ref-last-lp>334</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib3b">
            <xocs:ref-normalized-surname>HEIM</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1999</xocs:ref-pub-year>
            <xocs:ref-first-fp>75</xocs:ref-first-fp>
            <xocs:ref-last-lp>120</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref1">
            <xocs:ref-normalized-surname>YU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>97</xocs:ref-first-fp>
            <xocs:ref-last-lp>105</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref2">
            <xocs:ref-normalized-surname>PENSA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>100</xocs:ref-first-fp>
            <xocs:ref-last-lp>121</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
            <xocs:ref-normalized-srctitle>JAKSTATPATHWAYINDISEASE</xocs:ref-normalized-srctitle>
            <xocs:ref-normalized-article-title>STAT1STAT3INTUMORIGENESISTWOSIDESSAMECOIN</xocs:ref-normalized-article-title>
         </xocs:ref-info>
         <xocs:ref-info refid="sref3">
            <xocs:ref-normalized-surname>AMADIOBI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>711</xocs:ref-first-fp>
            <xocs:ref-last-lp>718</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref4">
            <xocs:ref-normalized-surname>COSTANTINO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>834</xocs:ref-first-fp>
            <xocs:ref-last-lp>843</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib8a">
            <xocs:ref-normalized-surname>MANKAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>1263</xocs:ref-first-fp>
            <xocs:ref-last-lp>1275</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib8b">
            <xocs:ref-normalized-surname>LAVECCHIA</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>2359</xocs:ref-first-fp>
            <xocs:ref-last-lp>2375</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>A</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib8c">
            <xocs:ref-normalized-surname>PAGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>65</xocs:ref-first-fp>
            <xocs:ref-last-lp>83</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref6">
            <xocs:ref-normalized-surname>DEBNATH</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>6645</xocs:ref-first-fp>
            <xocs:ref-last-lp>6668</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref7"/></xocs:ref-info>
         <xocs:ref-info refid="sref8">
            <xocs:ref-normalized-surname>BECKER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1998</xocs:ref-pub-year>
            <xocs:ref-first-fp>145</xocs:ref-first-fp>
            <xocs:ref-last-lp>151</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref9">
            <xocs:ref-normalized-surname>MARCOU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>195</xocs:ref-first-fp>
            <xocs:ref-last-lp>207</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref10">
            <xocs:ref-normalized-surname>BUETTNER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>432</xocs:ref-first-fp>
            <xocs:ref-last-lp>443</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref11">
            <xocs:ref-normalized-surname>KLAMPFER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2004</xocs:ref-pub-year>
            <xocs:ref-first-fp>30358</xocs:ref-first-fp>
            <xocs:ref-last-lp>30368</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>L</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref12">
            <xocs:ref-normalized-surname>SONG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>4700</xocs:ref-first-fp>
            <xocs:ref-last-lp>4705</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref13">
            <xocs:ref-normalized-surname>NIU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>2000</xocs:ref-first-fp>
            <xocs:ref-last-lp>2008</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref14">
            <xocs:ref-normalized-surname>BEDEL</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>1615</xocs:ref-first-fp>
            <xocs:ref-last-lp>1626</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>R</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref15">
            <xocs:ref-normalized-surname>EGWUAGU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>149</xocs:ref-first-fp>
            <xocs:ref-last-lp>156</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref16">
            <xocs:ref-normalized-surname>BHASIN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>391</xocs:ref-first-fp>
            <xocs:ref-last-lp>395</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref17">
            <xocs:ref-normalized-surname>REN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>454</xocs:ref-first-fp>
            <xocs:ref-last-lp>459</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref18">
            <xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>498</xocs:ref-first-fp>
            <xocs:ref-last-lp>507</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref19">
            <xocs:ref-normalized-surname>SCHUST</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>1235</xocs:ref-first-fp>
            <xocs:ref-last-lp>1242</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref20">
            <xocs:ref-normalized-surname>LI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>5592</xocs:ref-first-fp>
            <xocs:ref-last-lp>5596</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>H</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref21">
            <xocs:ref-normalized-surname>SHAHANI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>79</xocs:ref-first-fp>
            <xocs:ref-last-lp>84</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref22">
            <xocs:ref-normalized-surname>MATSUNO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>371</xocs:ref-first-fp>
            <xocs:ref-last-lp>375</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref23">
            <xocs:ref-normalized-surname>SATURNINO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>112</xocs:ref-first-fp>
            <xocs:ref-last-lp>119</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref24">
            <xocs:ref-normalized-surname>YU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>4402</xocs:ref-first-fp>
            <xocs:ref-last-lp>4412</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref25">
            <xocs:ref-normalized-surname>XU</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>4115</xocs:ref-first-fp>
            <xocs:ref-last-lp>4121</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref26">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>301</xocs:ref-first-fp>
            <xocs:ref-last-lp>310</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref27">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>2225</xocs:ref-first-fp>
            <xocs:ref-last-lp>2229</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref28">
            <xocs:ref-normalized-surname>SIDDIQUEE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>7391</xocs:ref-first-fp>
            <xocs:ref-last-lp>7396</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib32a">
            <xocs:ref-normalized-surname>FLETCHER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>1459</xocs:ref-first-fp>
            <xocs:ref-last-lp>1470</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib32b">
            <xocs:ref-normalized-surname>PAGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>5605</xocs:ref-first-fp>
            <xocs:ref-last-lp>5609</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib32c">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>1398</xocs:ref-first-fp>
            <xocs:ref-last-lp>1409</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib32d">
            <xocs:ref-normalized-surname>FLETCHER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>1959</xocs:ref-first-fp>
            <xocs:ref-last-lp>1964</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib32e">
            <xocs:ref-normalized-surname>HAO</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>4988</xocs:ref-first-fp>
            <xocs:ref-last-lp>4992</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>W</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib33a">
            <xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>9623</xocs:ref-first-fp>
            <xocs:ref-last-lp>9628</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>X</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib33b">
            <xocs:ref-normalized-surname>PAGE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2013</xocs:ref-pub-year>
            <xocs:ref-first-fp>7190</xocs:ref-first-fp>
            <xocs:ref-last-lp>7200</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>B</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib34a">
            <xocs:ref-normalized-surname>GUNNING</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2008</xocs:ref-pub-year>
            <xocs:ref-first-fp>2800</xocs:ref-first-fp>
            <xocs:ref-last-lp>2803</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib34b">
            <xocs:ref-normalized-surname>SIDDIQUEE</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>787</xocs:ref-first-fp>
            <xocs:ref-last-lp>798</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib34c">
            <xocs:ref-normalized-surname>MANDAI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>3394</xocs:ref-first-fp>
            <xocs:ref-last-lp>3397</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib34d">
            <xocs:ref-normalized-surname>COLEMAN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2005</xocs:ref-pub-year>
            <xocs:ref-first-fp>6661</xocs:ref-first-fp>
            <xocs:ref-last-lp>6670</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>D</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib34e">
            <xocs:ref-normalized-surname>SHAHANI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2011</xocs:ref-pub-year>
            <xocs:ref-first-fp>1823</xocs:ref-first-fp>
            <xocs:ref-last-lp>1838</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>V</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib34f">
            <xocs:ref-normalized-surname>GUNNING</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2007</xocs:ref-pub-year>
            <xocs:ref-first-fp>1875</xocs:ref-first-fp>
            <xocs:ref-last-lp>1878</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>P</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib35a">
            <xocs:ref-normalized-surname>SHUAI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1992</xocs:ref-pub-year>
            <xocs:ref-first-fp>1808</xocs:ref-first-fp>
            <xocs:ref-last-lp>1812</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>K</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="bib35b">
            <xocs:ref-normalized-surname>SCHINDLER</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1992</xocs:ref-pub-year>
            <xocs:ref-first-fp>809</xocs:ref-first-fp>
            <xocs:ref-last-lp>813</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>C</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref29">
            <xocs:ref-normalized-surname>BROMBERG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>1996</xocs:ref-pub-year>
            <xocs:ref-first-fp>7673</xocs:ref-first-fp>
            <xocs:ref-last-lp>7678</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>J</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref30">
            <xocs:ref-normalized-surname>DUNN</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2006</xocs:ref-pub-year>
            <xocs:ref-first-fp>836</xocs:ref-first-fp>
            <xocs:ref-last-lp>848</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>G</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref31">
            <xocs:ref-normalized-surname>HUANG</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2002</xocs:ref-pub-year>
            <xocs:ref-first-fp>2504</xocs:ref-first-fp>
            <xocs:ref-last-lp>2512</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref32"/></xocs:ref-info>
         <xocs:ref-info refid="sref33"/></xocs:ref-info>
         <xocs:ref-info refid="sref34"/></xocs:ref-info>
         <xocs:ref-info refid="sref35"/></xocs:ref-info>
         <xocs:ref-info refid="sref36">
            <xocs:ref-normalized-surname>KORB</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2009</xocs:ref-pub-year>
            <xocs:ref-first-fp>84</xocs:ref-first-fp>
            <xocs:ref-last-lp>96</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>O</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref37">
            <xocs:ref-normalized-surname>BIASINI</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2014</xocs:ref-pub-year>
            <xocs:ref-first-fp>252</xocs:ref-first-fp>
            <xocs:ref-last-lp>258</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>M</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref38">
            <xocs:ref-normalized-surname>TROTT</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2010</xocs:ref-pub-year>
            <xocs:ref-first-fp>455</xocs:ref-first-fp>
            <xocs:ref-last-lp>461</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>O</xocs:ref-normalized-initial>
         </xocs:ref-info>
         <xocs:ref-info refid="sref39">
            <xocs:ref-normalized-surname>YESYLEVSKYY</xocs:ref-normalized-surname>
            <xocs:ref-pub-year>2012</xocs:ref-pub-year>
            <xocs:ref-first-fp>1632</xocs:ref-first-fp>
            <xocs:ref-last-lp>1636</xocs:ref-last-lp>
            <xocs:ref-normalized-initial>S</xocs:ref-normalized-initial>
         </xocs:ref-info>
      </xocs:references>
      <xocs:refkeys>
         <xocs:refkey3>PALLANDREX2015X163</xocs:refkey3>
         <xocs:refkey4lp>PALLANDREX2015X163X174</xocs:refkey4lp>
         <xocs:refkey4ai>PALLANDREX2015X163XJ</xocs:refkey4ai>
         <xocs:refkey5>PALLANDREX2015X163X174XJ</xocs:refkey5>
      </xocs:refkeys>
      <xocs:open-access>
         <xocs:oa-article-status is-open-access="0" is-open-archive="0"/></xocs:oa-article-status>
      </xocs:open-access>
      <xocs:self-archiving>
         <xocs:sa-embargo-status>UnderEmbargo</xocs:sa-embargo-status>
         <xocs:sa-start-date>2017-09-06T00:00:00Z</xocs:sa-start-date>
         <xocs:sa-user-license>http://creativecommons.org/licenses/by-nc-nd/4.0/</xocs:sa-user-license>
      </xocs:self-archiving>
      <xocs:attachment-metadata-doc>
         <xocs:attachment-set-type>item</xocs:attachment-set-type>
         <xocs:pii-formatted>S0223-5234(15)30237-3</xocs:pii-formatted>
         <xocs:pii-unformatted>S0223523415302373</xocs:pii-unformatted>
         <xocs:eid>1-s2.0-S0223523415302373</xocs:eid>
         <xocs:doi>10.1016/j.ejmech.2015.08.054</xocs:doi>
         <xocs:cid>271932</xocs:cid>
         <xocs:timestamp>2016-02-22T04:44:54.383328-05:00</xocs:timestamp>
         <xocs:cover-date-start>2015-10-20</xocs:cover-date-start>
         <xocs:attachments>
            <xocs:web-pdf>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-main.pdf</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/MAIN/application/pdf/06190885c370a2274b3161dffca838cd/main.pdf</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/MAIN/application/pdf/06190885c370a2274b3161dffca838cd/main.pdf</xocs:ucs-locator>
               <xocs:filename>main.pdf</xocs:filename>
               <xocs:extension>pdf</xocs:extension>
               <xocs:pdf-optimized>true</xocs:pdf-optimized>
               <xocs:filesize>2518265</xocs:filesize>
               <xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose>
               <xocs:web-pdf-page-count>12</xocs:web-pdf-page-count>
               <xocs:web-pdf-images>
                  <xocs:web-pdf-image>
                     <xocs:attachment-eid>1-s2.0-S0223523415302373-main_1.png</xocs:attachment-eid>
                     <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/PREVIEW/image/png/169f2b7cbd04ae30978634b1d4b5d6b4/main_1.png</xocs:ucs-locator>
                     <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/PREVIEW/image/png/169f2b7cbd04ae30978634b1d4b5d6b4/main_1.png</xocs:ucs-locator>
                     <xocs:filename>main_1.png</xocs:filename>
                     <xocs:extension>png</xocs:extension>
                     <xocs:filesize>55242</xocs:filesize>
                     <xocs:pixel-height>849</xocs:pixel-height>
                     <xocs:pixel-width>656</xocs:pixel-width>
                     <xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type>
                     <xocs:pdf-page-num>1</xocs:pdf-page-num>
                  </xocs:web-pdf-image>
               </xocs:web-pdf-images>
            </xocs:web-pdf>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-fx1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/fx1/THUMBNAIL/image/gif/c4b62c33393f44f3df34b2e3a6b9f10a/fx1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/fx1/THUMBNAIL/image/gif/c4b62c33393f44f3df34b2e3a6b9f10a/fx1.sml</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>8850</xocs:filesize>
               <xocs:pixel-height>57</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-fx2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/fx2/THUMBNAIL/image/gif/7717f6b034f05d951a4b7baff86ef254/fx2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/fx2/THUMBNAIL/image/gif/7717f6b034f05d951a4b7baff86ef254/fx2.sml</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>13715</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>120</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr1.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr1/THUMBNAIL/image/gif/07cf593c1d6927454e618af60efb7e7a/gr1.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr1/THUMBNAIL/image/gif/07cf593c1d6927454e618af60efb7e7a/gr1.sml</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>18321</xocs:filesize>
               <xocs:pixel-height>164</xocs:pixel-height>
               <xocs:pixel-width>119</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr2.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr2/THUMBNAIL/image/gif/91b105bdd062c915c849e7fbdb9dd7a3/gr2.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr2/THUMBNAIL/image/gif/91b105bdd062c915c849e7fbdb9dd7a3/gr2.sml</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>16901</xocs:filesize>
               <xocs:pixel-height>89</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr3.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr3/THUMBNAIL/image/gif/8cce7c5509ba4046e60f68c56c0ee247/gr3.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr3/THUMBNAIL/image/gif/8cce7c5509ba4046e60f68c56c0ee247/gr3.sml</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>6335</xocs:filesize>
               <xocs:pixel-height>33</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr4.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr4/THUMBNAIL/image/gif/bd4bbf29ac62bdc87e44d362ee97dc5b/gr4.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr4/THUMBNAIL/image/gif/bd4bbf29ac62bdc87e44d362ee97dc5b/gr4.sml</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>17835</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>142</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr5.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr5/THUMBNAIL/image/gif/66596f456a1bc190be7fb040cd164de0/gr5.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr5/THUMBNAIL/image/gif/66596f456a1bc190be7fb040cd164de0/gr5.sml</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>13787</xocs:filesize>
               <xocs:pixel-height>129</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr6.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr6/THUMBNAIL/image/gif/647fd7facf307ca75218f3cff566bc5e/gr6.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr6/THUMBNAIL/image/gif/647fd7facf307ca75218f3cff566bc5e/gr6.sml</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>15071</xocs:filesize>
               <xocs:pixel-height>163</xocs:pixel-height>
               <xocs:pixel-width>94</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr7.sml</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr7/THUMBNAIL/image/gif/b5a6ce6dfffd05af86750fa067309556/gr7.sml</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr7/THUMBNAIL/image/gif/b5a6ce6dfffd05af86750fa067309556/gr7.sml</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.sml</xocs:filename>
               <xocs:extension>sml</xocs:extension>
               <xocs:filesize>15737</xocs:filesize>
               <xocs:pixel-height>120</xocs:pixel-height>
               <xocs:pixel-width>219</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-fx1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/fx1/DOWNSAMPLED/image/jpeg/c150b5171629893dfac40893c0f1fdbf/fx1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/fx1/DOWNSAMPLED/image/jpeg/c150b5171629893dfac40893c0f1fdbf/fx1.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx1</xocs:file-basename>
               <xocs:abstract-attachment>true</xocs:abstract-attachment>
               <xocs:filename>fx1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>38264</xocs:filesize>
               <xocs:pixel-height>129</xocs:pixel-height>
               <xocs:pixel-width>500</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-fx2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/fx2/DOWNSAMPLED/image/jpeg/e161791f352e760cd2ff0ae2750bba65/fx2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/fx2/DOWNSAMPLED/image/jpeg/e161791f352e760cd2ff0ae2750bba65/fx2.jpg</xocs:ucs-locator>
               <xocs:file-basename>fx2</xocs:file-basename>
               <xocs:filename>fx2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>207971</xocs:filesize>
               <xocs:pixel-height>1002</xocs:pixel-height>
               <xocs:pixel-width>734</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr1.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr1/DOWNSAMPLED/image/jpeg/50997d2f84dcdcfd9cadafe8eee98632/gr1.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr1/DOWNSAMPLED/image/jpeg/50997d2f84dcdcfd9cadafe8eee98632/gr1.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr1</xocs:file-basename>
               <xocs:filename>gr1.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>113023</xocs:filesize>
               <xocs:pixel-height>738</xocs:pixel-height>
               <xocs:pixel-width>535</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr2.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr2/DOWNSAMPLED/image/jpeg/f1c17f93e29b3ca10cefb396891d9cc5/gr2.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr2/DOWNSAMPLED/image/jpeg/f1c17f93e29b3ca10cefb396891d9cc5/gr2.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr2</xocs:file-basename>
               <xocs:filename>gr2.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>66464</xocs:filesize>
               <xocs:pixel-height>234</xocs:pixel-height>
               <xocs:pixel-width>578</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr3.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr3/DOWNSAMPLED/image/jpeg/95e6fcc8f4c9988380061492e3f853b0/gr3.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr3/DOWNSAMPLED/image/jpeg/95e6fcc8f4c9988380061492e3f853b0/gr3.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr3</xocs:file-basename>
               <xocs:filename>gr3.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>23892</xocs:filesize>
               <xocs:pixel-height>112</xocs:pixel-height>
               <xocs:pixel-width>734</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr4.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr4/DOWNSAMPLED/image/jpeg/948bb0855817f7d0a33a2906f042e9d4/gr4.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr4/DOWNSAMPLED/image/jpeg/948bb0855817f7d0a33a2906f042e9d4/gr4.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr4</xocs:file-basename>
               <xocs:filename>gr4.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>78927</xocs:filesize>
               <xocs:pixel-height>447</xocs:pixel-height>
               <xocs:pixel-width>388</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr5.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr5/DOWNSAMPLED/image/jpeg/011b90b56cd2efdc5fa24e8f253e41a2/gr5.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr5/DOWNSAMPLED/image/jpeg/011b90b56cd2efdc5fa24e8f253e41a2/gr5.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr5</xocs:file-basename>
               <xocs:filename>gr5.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>53507</xocs:filesize>
               <xocs:pixel-height>316</xocs:pixel-height>
               <xocs:pixel-width>535</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr6.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr6/DOWNSAMPLED/image/jpeg/9d241936f130163689481244090e4d61/gr6.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr6/DOWNSAMPLED/image/jpeg/9d241936f130163689481244090e4d61/gr6.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr6</xocs:file-basename>
               <xocs:filename>gr6.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>126028</xocs:filesize>
               <xocs:pixel-height>1007</xocs:pixel-height>
               <xocs:pixel-width>580</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-gr7.jpg</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/gr7/DOWNSAMPLED/image/jpeg/8824d3b6c1f5bee16ca1940108ff3ebf/gr7.jpg</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/gr7/DOWNSAMPLED/image/jpeg/8824d3b6c1f5bee16ca1940108ff3ebf/gr7.jpg</xocs:ucs-locator>
               <xocs:file-basename>gr7</xocs:file-basename>
               <xocs:filename>gr7.jpg</xocs:filename>
               <xocs:extension>jpg</xocs:extension>
               <xocs:filesize>80855</xocs:filesize>
               <xocs:pixel-height>390</xocs:pixel-height>
               <xocs:pixel-width>711</xocs:pixel-width>
               <xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type>
            </xocs:attachment>
            <xocs:attachment>
               <xocs:attachment-eid>1-s2.0-S0223523415302373-mmc1.doc</xocs:attachment-eid>
               <xocs:ucs-locator>https://s3-eu-west-1.amazonaws.com/prod-ucs-content-store-eu-west/content/pii:S0223523415302373/mmc1/MAIN/application/msword/58e522b4725fcb962a2612c402d2f82b/mmc1.doc</xocs:ucs-locator>
               <xocs:ucs-locator>https://s3.amazonaws.com/prod-ucs-content-store-us-east/content/pii:S0223523415302373/mmc1/MAIN/application/msword/58e522b4725fcb962a2612c402d2f82b/mmc1.doc</xocs:ucs-locator>
               <xocs:file-basename>mmc1</xocs:file-basename>
               <xocs:filename>mmc1.doc</xocs:filename>
               <xocs:extension>doc</xocs:extension>
               <xocs:filesize>12992000</xocs:filesize>
               <xocs:attachment-type>APPLICATION</xocs:attachment-type>
            </xocs:attachment>
         </xocs:attachments>
      </xocs:attachment-metadata-doc>
   </xocs:meta><xocs:serial-item xmlns:xoe="http://www.elsevier.com/xml/xoe/dtd">
      <article xmlns="http://www.elsevier.com/xml/ja/dtd" docsubtype="fla" version="5.4" xml:lang="en">
         <item-info>
            <jid>EJMECH</jid>
            <aid>8090</aid>
            <ce:pii>S0223-5234(15)30237-3</ce:pii>
            <ce:doi>10.1016/j.ejmech.2015.08.054</ce:doi>
            <ce:copyright type="full-transfer" year="2015">Elsevier Masson SAS</ce:copyright>
         </item-info>
         <ce:floats>
            <ce:figure id="fig1">
               <ce:label>Fig. 1</ce:label>
               <ce:caption id="cap0010">
                  <ce:simple-para id="fspara0010" view="all">Virtual screening identification of compound 5 as STAT3 inhibitor A) Structures of potential STAT3 inhibitors identified by virtual screening. <ce:sup loc="post">
                        <ce:italic>a</ce:italic>
                     </ce:sup>supplier code B) Docking pose of compound <ce:bold>5</ce:bold> in the SH2 domain of STAT3 (PDB code: <ce:inter-ref xlink:href="pdb:1BG1" id="intref0020" xlink:type="simple">1BG1</ce:inter-ref>) <ce:cross-ref refid="bib11" id="crosref0480">[11]</ce:cross-ref>. The STAT3 backbone structure is displayed as a grey ribbon with α-helices as cylinders and β-strands as arrows. Important STAT3 side chains (cyan carbon atoms) for compound <ce:bold>5</ce:bold> (yellow carbon atoms) binding are indicated as sticks. Other heteroatoms (nitrogen, oxygen, chlorine) are colored in blue, red and green, respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr1"/></ce:link>
            </ce:figure>
            <ce:figure id="fig2">
               <ce:label>Fig. 2</ce:label>
               <ce:caption id="cap0015">
                  <ce:simple-para id="fspara0015" view="all">STAT3 vs STAT1 selectivity test using STAT-luciferase promoter arrays Luciferase reporter induction after exposure to compounds <ce:bold>1</ce:bold> to <ce:bold>9</ce:bold> and STA21 (final concentration 50 μM) in HeLa/STAT3-luc cells (A) and HeLa/STAT1-Luc cells (B) respectively. DMSO are blank containing all components except oncostatin M, OSM and IFNγ are control where only the inhibitor was replaced by the buffer solution (100% of induction). Results are presented as the average ± standard error of three independent assays.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr2"/></ce:link>
            </ce:figure>
            <ce:figure id="fig3">
               <ce:label>Fig. 3</ce:label>
               <ce:caption id="cap0020">
                  <ce:simple-para id="fspara0020" view="all">Synthesis of compounds 5 and 23. Reagents and conditions: (i) Na<ce:inf loc="post">2</ce:inf>CO<ce:inf loc="post">3</ce:inf>, dry DMF, rt, overnight, <ce:bold>42</ce:bold>: 85% <ce:bold>46</ce:bold>: 84%; (ii) 5-aminotetrazole, NaBH<ce:inf loc="post">3</ce:inf>CN, CH<ce:inf loc="post">2</ce:inf>Cl<ce:inf loc="post">2</ce:inf> – MeOH, rt, overnight, <ce:bold>5</ce:bold>: 40%, <ce:bold>23</ce:bold>: 56%.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr3"/></ce:link>
            </ce:figure>
            <ce:figure id="fig4">
               <ce:label>Fig. 4</ce:label>
               <ce:caption id="cap0025">
                  <ce:simple-para id="fspara0025" view="all">Probability density distribution of docking binding scores on human STAT3 homology model. Binding scores resulted from docking on 200 frames extracted from molecular dynamics trajectory of human STAT3 homology model for compounds <ce:bold>23</ce:bold> (black), <ce:bold>5</ce:bold> (red) and <ce:bold>35</ce:bold> (black) which are aminotetrazole derivatives* and <ce:bold>42</ce:bold>, <ce:bold>46</ce:bold> (green), <ce:bold>45</ce:bold> (red) and <ce:bold>43</ce:bold>, <ce:bold>49</ce:bold> (blue) which are aldehyde, carboxylic acid and cyanamide derivatives respectively. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr4"/></ce:link>
            </ce:figure>
            <ce:figure id="fig5">
               <ce:label>Fig. 5</ce:label>
               <ce:caption id="cap0030">
                  <ce:simple-para id="fspara0030" view="all">Binding affinity to STAT3 and STAT1 of compounds 5, 43, 42, 23, 45, 46, 49. Specific binding on SH2 domain are determined in fluorescence-polarization assay respectively with A) 5-FAM–G(pTyr)LPQTV-CONH<ce:inf loc="post">2</ce:inf> a STAT3-bound fluorescently labeled peptide and B) 5-FAM-G(pTyr)YIKTE-CONH<ce:inf loc="post">2</ce:inf> a STAT1-bound fluorescently labeled peptide.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr5"/></ce:link>
            </ce:figure>
            <ce:figure id="fig6">
               <ce:label>Fig. 6</ce:label>
               <ce:caption id="cap0035">
                  <ce:simple-para id="fspara0035" view="all">Effect of 23 at various doses on the STAT3 activity and translocation into nucleus. A) STAT3 and STAT1 luciferase activities at various doses; B) phospho-STAT3 of (1) HeLa total extract, (2) B9 total extract, (3) HeLa cytoplasm fraction, (4) HeLa nuclear fraction, (5) B9 cytoplasm fraction, (6) B9 nuclear fraction, after exposure to Oncostatin M observed by western blot; C) Confocal microscopy on HeLa cells without and after exposure to <ce:bold>23</ce:bold> at 100 μM and revealed by anti-p-Tyr-STAT3 (pTyr705) (3E2) and anti-STAT3 (79D7). DAPI was used for nuclear staining (Molecular Probes).</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr6"/></ce:link>
            </ce:figure>
            <ce:figure id="fig7">
               <ce:label>Fig. 7</ce:label>
               <ce:caption id="cap0040">
                  <ce:simple-para id="fspara0040" view="all">Effect of 23 on the survival of cultured cell lines. A) MTT viability test on B9 myeloma cell line, MDA-MB-231 breast cancer cell line and MDA-MB-231 transfected with STAT3C, a disulfide bond dimerized; B) IFN-γ production by NK in the coculture PBL – HT29 after exposure to <ce:bold>23</ce:bold> at 50 μM; C) ROR-γt, Tbet and FoxP3 (specific transcription factor for Th17, Th1 and Treg respectively) production by naïve human CD4 T lymphocytes activated by activated by anti-CD3 and anti-CD28 activating monoclonal antibodies in the presence of IL6 and TGF-β1 (Th17 conditions) or IL12 (Th1 conditions) and IL-2 with TGF-b (Treg conditions) after exposure to <ce:bold>23</ce:bold> at 50 μM.</ce:simple-para>
               </ce:caption>
               <ce:link locator="gr7"/></ce:link>
            </ce:figure>
            <ce:table xmlns="http://www.elsevier.com/xml/common/cals/dtd" id="tbl1" frame="none" colsep="0" rowsep="0">
               <ce:label>Table 1</ce:label>
               <ce:caption id="cap0045">
                  <ce:simple-para id="tspara0010" view="all">Structure Activity Relationships (SAR) of compound 5 derivatives<ce:sup loc="post">a</ce:sup>.</ce:simple-para>
               </ce:caption>
               <ce:link locator="fx2"/></ce:link>
            </ce:table>
         </ce:floats>
         <head>
            <ce:dochead id="dhead0010">
               <ce:textfn>Research paper</ce:textfn>
            </ce:dochead>
            <ce:title id="title0010">Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors</ce:title>
            <ce:author-group id="augrp0010">
               <ce:author id="au1">
                  <ce:given-name>Jean-René</ce:given-name>
                  <ce:surname>Pallandre</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0010">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au2">
                  <ce:given-name>Christophe</ce:given-name>
                  <ce:surname>Borg</ce:surname>
                  <ce:cross-ref refid="aff1" id="crosref0015">
                     <ce:sup loc="post">a</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au3">
                  <ce:given-name>Didier</ce:given-name>
                  <ce:surname>Rognan</ce:surname>
                  <ce:cross-ref refid="aff2" id="crosref0020">
                     <ce:sup loc="post">b</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au4">
                  <ce:given-name>Thibault</ce:given-name>
                  <ce:surname>Boibessot</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0025">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au5">
                  <ce:given-name>Vincent</ce:given-name>
                  <ce:surname>Luzet</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0030">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au6">
                  <ce:given-name>Semen</ce:given-name>
                  <ce:surname>Yesylevskyy</ce:surname>
                  <ce:cross-ref refid="aff4" id="crosref0035">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="aff5" id="crosref0040">
                     <ce:sup loc="post">e</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au7">
                  <ce:given-name>Christophe</ce:given-name>
                  <ce:surname>Ramseyer</ce:surname>
                  <ce:cross-ref refid="aff4" id="crosref0045">
                     <ce:sup loc="post">d</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:author id="au8" orcid="0000-0002-3575-0253">
                  <ce:given-name>Marc</ce:given-name>
                  <ce:surname>Pudlo</ce:surname>
                  <ce:cross-ref refid="aff3" id="crosref0050">
                     <ce:sup loc="post">c</ce:sup>
                  </ce:cross-ref>
                  <ce:cross-ref refid="cor1" id="crosref0055">
                     <ce:sup loc="post">∗</ce:sup>
                  </ce:cross-ref>
                  
               </ce:author>
               <ce:affiliation id="aff1">
                  <ce:label>a</ce:label>
                  <ce:textfn>Inserm 1098, EFS Bourgogne Franche Comté, University of Franche-Comté, IFR133, 8 rue du Dr Girod, 25020 Besançon, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Inserm 1098, EFS Bourgogne Franche Comté</sa:organization>
                     <sa:organization>University of Franche-Comté</sa:organization>
                     <sa:organization>IFR133</sa:organization>
                     <sa:address-line>8 rue du Dr Girod</sa:address-line>
                     <sa:city>Besançon</sa:city>
                     <sa:postal-code>25020</sa:postal-code>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff2">
                  <ce:label>b</ce:label>
                  <ce:textfn>Laboratory for Therapeutical Innovation, UMR 7200 Université de Strasbourg/CNRS, MEDALIS Drug Discovery Center, F-67400 Illkirch, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Laboratory for Therapeutical Innovation</sa:organization>
                     <sa:organization>UMR 7200 Université de Strasbourg/CNRS</sa:organization>
                     <sa:organization>MEDALIS Drug Discovery Center</sa:organization>
                     <sa:city>Illkirch</sa:city>
                     <sa:postal-code>F-67400</sa:postal-code>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff3">
                  <ce:label>c</ce:label>
                  <ce:textfn>Nanomedicine Lab, EA – 4662, UFR SMP 19 rue Ambroise Paré Université de Franche Comté, 25030 Besançon Cedex, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Nanomedicine Lab</sa:organization>
                     <sa:organization>EA – 4662, UFR SMP 19 rue Ambroise Paré Université de Franche Comté</sa:organization>
                     <sa:city>Besançon Cedex</sa:city>
                     <sa:postal-code>25030</sa:postal-code>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff4">
                  <ce:label>d</ce:label>
                  <ce:textfn>Laboratoire Chrono Environnement UMR CNRS 6249, Faculté des Sciences et Techniques, La Bouloie, Université de Franche-Comté, 25030, Besançon Cedex, France</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Laboratoire Chrono Environnement UMR CNRS 6249</sa:organization>
                     <sa:organization>Faculté des Sciences et Techniques, La Bouloie</sa:organization>
                     <sa:organization>Université de Franche-Comté</sa:organization>
                     <sa:city>Besançon Cedex</sa:city>
                     <sa:postal-code>25030</sa:postal-code>
                     <sa:country>France</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:affiliation id="aff5">
                  <ce:label>e</ce:label>
                  <ce:textfn>Institute of Physics, National Academy of Sciences of Ukraine, Prospect Nauki, 46, Kyiv, 03039, Ukraine</ce:textfn>
                  <sa:affiliation>
                     <sa:organization>Institute of Physics</sa:organization>
                     <sa:organization>National Academy of Sciences of Ukraine</sa:organization>
                     <sa:address-line>Prospect Nauki, 46</sa:address-line>
                     <sa:city>Kyiv</sa:city>
                     <sa:postal-code>03039</sa:postal-code>
                     <sa:country>Ukraine</sa:country>
                  </sa:affiliation>
               </ce:affiliation>
               <ce:correspondence id="cor1">
                  <ce:label>∗</ce:label>
                  <ce:text>Corresponding author.</ce:text>
               </ce:correspondence>
            </ce:author-group>
            <ce:date-received day="2" month="7" year="2015"/></ce:date-received>
            <ce:date-revised day="25" month="8" year="2015"/></ce:date-revised>
            <ce:date-accepted day="27" month="8" year="2015"/></ce:date-accepted>
            <ce:abstract xml:lang="en" id="abs0010" view="all" class="author"><ce:abstract-sec id="abssec0010" view="all">
                  <ce:simple-para id="abspara0010" view="all">The development of inhibitors blocking STAT3 transcriptional activity is a promising therapeutic approach against cancer and inflammatory diseases. In this context, the selectivity of inhibitors against the STAT1 transcription factor is crucial as STAT3 and STAT1 play opposite roles in the apoptosis of tumor cells and polarization of the immune response. A structure-based virtual screening followed by a luciferase-containing promoter assay on STAT3 and STAT1 signaling were used to identify a selective STAT3 inhibitor. An important role of the aminotetrazole group in modulating STAT3 and STAT1 inhibitory activities has been established. Optimization of the hit compound leads to <ce:bold>23</ce:bold>. This compound inhibits growth and survival of cells with STAT3 signaling pathway while displaying a minimal effect on STAT1 signaling. Moreover, it prevents lymphocyte T polarization into Th17 and Treg without affecting their differentiation into Th1 lymphocyte.</ce:simple-para>
               </ce:abstract-sec></ce:abstract>
            <ce:abstract class="graphical" id="abs0015" view="all">
               <ce:section-title id="sectitle0015">Graphical abstract</ce:section-title>
               <ce:abstract-sec id="abssec0015" view="all">
                  <ce:simple-para id="abspara0015" view="all">
                     <ce:display>
                        <ce:figure id="undfig1">
                           <ce:link locator="fx1"/></ce:link>
                        </ce:figure>
                     </ce:display>
                  </ce:simple-para>
               </ce:abstract-sec>
            </ce:abstract>
            
            <ce:keywords xml:lang="en" id="kwrds0010" view="all" class="keyword">
               <ce:section-title id="sectitle0025">Keywords</ce:section-title>
               <ce:keyword id="kwrd0010">
                  <ce:text>STAT3</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0015">
                  <ce:text>Small-molecule inhibitor</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0020">
                  <ce:text>Aminotetrazole</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0025">
                  <ce:text>Anticancer drug</ce:text>
               </ce:keyword>
               <ce:keyword id="kwrd0030">
                  <ce:text>Inflammation</ce:text>
               </ce:keyword>
            </ce:keywords>
            <ce:keywords xml:lang="en" class="abr" id="kwrds0015" view="all">
               <ce:section-title id="sectitle0030">Abbreviations</ce:section-title>
               <ce:keyword id="kwrd0035">
                  <ce:text>STAT</ce:text>
                  <ce:keyword id="kwrd0040">
                     <ce:text>signal transducer and activation of transcription</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0045">
                  <ce:text>SH2</ce:text>
                  <ce:keyword id="kwrd0050">
                     <ce:text>Src Homoly 2</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0055">
                  <ce:text>Th</ce:text>
                  <ce:keyword id="kwrd0060">
                     <ce:text>T helper</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0065">
                  <ce:text>OSM</ce:text>
                  <ce:keyword id="kwrd0070">
                     <ce:text>oncostatin M</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0075">
                  <ce:text>MTT</ce:text>
                  <ce:keyword id="kwrd0080">
                     <ce:text>3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</ce:text>
                  </ce:keyword>
               </ce:keyword>
               <ce:keyword id="kwrd0085">
                  <ce:text>NK</ce:text>
                  <ce:keyword id="kwrd0090">
                     <ce:text>Natural Killer</ce:text>
                  </ce:keyword>
               </ce:keyword>
            </ce:keywords>
         </head>
         <body view="all">
            <ce:sections>
               <ce:section id="sec1" role="introduction" view="all">
                  <ce:label>1</ce:label>
                  <ce:section-title id="sectitle0035">Introduction</ce:section-title>
                  <ce:para id="p0035" view="all">Signal Transducers and Activators of Transcription (STATs) are a family of seven cytoplasmic transcription factors (STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b and STAT6) with critical roles in the regulation of cell growth, cell differentiation, inflammation and immune response <ce:cross-refs refid="bib1 bib1a" id="crosrefs0010">[1]</ce:cross-refs>. STAT proteins possess six structural regions including a N-domain, a coiled-coil domain, a DNA-binding domain, a linker domain, a Src Homology 2 (SH2) domain involved in protein–protein interaction regulation and a transcription activation domain.</ce:para>
                  <ce:para id="p0040" view="all">STAT3 activation is mediated mainly by Src proteins or growth factor receptors. Activated Jak kinases phosphorylate tyrosine residues in the intracellular domains of these receptors <ce:cross-refs refid="bib2 bib2a bib2b" id="crosrefs0015">[2]</ce:cross-refs>. STAT monomers bind with their SH2 domains to these receptor-docking sites allowing further interactions of STAT with Jak tyrosine kinases. Jak phosphorylates the tyrosine located at the C-terminal end of the STAT3 SH2 domain resulting in dimer formation through mutual SH2 domain-phosphotyrosine interactions. STAT dimers then translocate into the nucleus to mediate selective transcriptional activity <ce:cross-refs refid="bib3 bib3a bib3b" id="crosrefs0020">[3]</ce:cross-refs>.</ce:para>
                  <ce:para id="p0045" view="all">Besides the transient activation in normal cells, constitutive or inappropriate activation of STAT3 has been found to directly contribute to oncogenesis in a wide variety of cancers <ce:cross-ref refid="bib4" id="crosref0060">[4]</ce:cross-ref>. In contrast, STAT1 is thought to play an opposite role via anti-proliferative and pro-apoptotic activities in tumor cells <ce:cross-ref refid="bib5" id="crosref0065">[5]</ce:cross-ref>. In addition, a transcriptional response to each STAT protein activation is highly specific and provides polarization of the immune response. An involvement of T helper 17 (Th17) lymphocyte polarization contributes to the initiation of inflammatory diseases as highlighted in colitis or psoriasis models. Here again, the balance between STAT3 and STAT1 was shown to be an important component in the tuning of the immune response as STAT3 activation is associated with Th17 polarization while STAT1 signaling prevents Th17 polarization <ce:cross-ref refid="bib6" id="crosref0070">[6]</ce:cross-ref>. Therefore, the development of inhibitors blocking STAT3 transcriptional activity is a relevant clinical issue <ce:cross-ref refid="bib7" id="crosref0075">[7]</ce:cross-ref> and the selectivity against STAT1 is crucial for the development of new STAT3 inhibitors with interesting pharmacodynamic profiles.</ce:para>
                  <ce:para id="p0050" view="all">Since indirect STAT3 blockade by Jak inhibitors is poorly selective and could therefore cause severe adverse effects, several approaches have been taken to directly inhibit STAT3 dimerization <ce:cross-refs refid="bib8 bib8a bib8b bib8c" id="crosrefs0025">[8]</ce:cross-refs>. Several peptides and phosphopeptides were designed to mimic the amino acid sequence of STAT3, which interacts with the SH2 domain upon dimerization. However, strategies based on such peptides have shown several limitations including low cell permeability and stability. Therefore, attention has been shifted towards small non-peptidic inhibitors <ce:cross-ref refid="bib9" id="crosref0080">[9]</ce:cross-ref> with better pharmacokinetic properties. Here, we aimed to design non-peptidic small molecules inhibiting STAT3 activity with enhanced selectivity against STAT1. For this purpose, a structure-based virtual screening approach was used to identify commercially available chemical compounds with the potential to bind STAT3 to the SH2 domain. A luciferase-containing promoter assay was used to investigate the activity of each candidate on STAT3 and STAT1 signaling. This approach led to the identification of a prospective selective STAT3 inhibitor (<ce:bold>5</ce:bold>). Then, an extensive structure activity relationships study was performed resulting in the molecule <ce:bold>23</ce:bold> and some other derivatives. We demonstrate that an aminotetrazole group included in the hydrophilic moiety impaired the ability of selected chemical compounds to bind STAT1 while maintaining STAT3 inhibition. The inhibitor <ce:bold>23</ce:bold> does not influence STAT1 signaling and is effective <ce:italic>in vitro</ce:italic> in blocking STAT3-dependent physiological functions, such as cancer cell proliferation and Th17 polarization.</ce:para>
               </ce:section>
               <ce:section id="sec2" role="results" view="all">
                  <ce:label>2</ce:label>
                  <ce:section-title id="sectitle0040">Results</ce:section-title>
                  <ce:section id="sec2.1" view="all">
                     <ce:label>2.1</ce:label>
                     <ce:section-title id="sectitle0045">Virtual screening for non-peptide inhibitors of STAT3 SH2 domain</ce:section-title>
                     <ce:para id="p0055" view="all">The potential interest to target the SH2 domain of STAT3 using non peptide low molecular-weight compounds prompted us to identify prospective inhibitors by a docking-based virtual screening of a commercially available compound library <ce:cross-ref refid="bib10" id="crosref0085">[10]</ce:cross-ref> targeting the available crystal structure of mouse STAT3 SH2 domain <ce:cross-ref refid="bib11" id="crosref0090">[11]</ce:cross-ref>. The well-known pTyr705-binding site (Lys591, Arg609, Ser611, Ser613) of the Stat3β homodimer was specifically selected for high-throughput docking. Virtual hit selection was based on knowledge-based scoring <ce:cross-ref refid="bib12" id="crosref0095">[12]</ce:cross-ref> aimed at identifying compounds, which share key interactions to the Stat3 pTyr705 binding site with the co-crystallized phosphorylated peptide (Ala<ce:sup loc="post">703</ce:sup>-Pro<ce:sup loc="post">704</ce:sup>-pTyr<ce:sup loc="post">705</ce:sup>-Leu<ce:sup loc="post">706</ce:sup>-Lys<ce:sup loc="post">707</ce:sup>). A list of 9 out of 52 candidates was selected (<ce:cross-ref refid="fig1" id="crosref0100">Fig. 1</ce:cross-ref>
                        <ce:float-anchor refid="fig1"/></ce:float-anchor>A) based on commercial availability and the aqueous solubility of compounds. Compounds were then purchased and tested for their ability to inhibit STAT3 signaling <ce:italic>in vitro</ce:italic>. For this purpose a luciferase promoter assay including STAT3 response elements was used as described previously <ce:cross-ref refid="bib13" id="crosref0105">[13]</ce:cross-ref>. Genetically modified HeLa cells with the luciferase STAT3-promoter array were exposed to 50 μM of selected candidate compounds and treated with Oncostatin M in order to activate STAT3. Inhibitions of STAT3 luciferase activity of all studied compounds are shown in <ce:cross-ref refid="fig2" id="crosref0110">Fig. 2</ce:cross-ref>
                        <ce:float-anchor refid="fig2"/></ce:float-anchor>. All candidates prevented the induction of luciferase activity following Oncostatin M treatment. Compounds <ce:bold>2</ce:bold> and <ce:bold>6</ce:bold> were cytotoxic on Hela cells (data not shown) and were excluded from further analysis.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.2" view="all">
                     <ce:label>2.2</ce:label>
                     <ce:section-title id="sectitle0050">Influence of the selected STAT3 inhibitors on STAT1 activity</ce:section-title>
                     <ce:para id="p0060" view="all">The selectivity of selected compounds for STAT3 vs. STAT1 inhibition was tested as follows. HeLa cells containing a luciferase promoter array with STAT1 response elements were used <ce:cross-ref refid="bib14" id="crosref0115">[14]</ce:cross-ref>. STAT1 signaling was induced by interferon γ. STAT3 luciferase assays were performed in parallel to determine the selectivity of each inhibitor. The well-known STAT3 SH2 domain inhibitor STA21 <ce:cross-ref refid="bib15" id="crosref0120">[15]</ce:cross-ref>, was used as a control for STAT3 inhibition. The final concentration of all candidates and STA21 was set to 50 μM. The candidate <ce:bold>5</ce:bold> displayed selectivity close to that achieved with STA21 (<ce:cross-ref refid="fig2" id="crosref0125">Fig. 2</ce:cross-ref>). This compound was therefore synthesized in our laboratory to confirm initial screening results and for further experiments. (<ce:cross-ref refid="fig3" id="crosref0130">Fig. 3</ce:cross-ref>
                        <ce:float-anchor refid="fig3"/></ce:float-anchor>)</ce:para>
                  </ce:section>
                  <ce:section id="sec2.3" view="all">
                     <ce:label>2.3</ce:label>
                     <ce:section-title id="sectitle0055">Structure-activity relationships and development of inhibitor 23</ce:section-title>
                     <ce:para id="p0065" view="all">An extensive structure-activity relationships study was performed by synthetizing analogues of <ce:bold>5</ce:bold> where each of three radicals R<ce:inf loc="post">1</ce:inf>, R<ce:inf loc="post">2</ce:inf>, R<ce:inf loc="post">3</ce:inf> (see <ce:cross-ref refid="tbl1" id="crosref0135">Table 1</ce:cross-ref>
                        <ce:float-anchor refid="tbl1"/></ce:float-anchor>) was substituted by different chemical groups. The stages of chemical synthesis of <ce:bold>5</ce:bold> and <ce:bold>23</ce:bold> are shown in <ce:cross-ref refid="fig3" id="crosref0140">Fig. 3</ce:cross-ref> whereas that of all other derivatives is shown in <ce:cross-ref refid="appsec1" id="crosref0145">Figs. S1–S12</ce:cross-ref>. Each compound was assessed in STAT3 and STAT1-luciferase reporter assays to evaluate its effect on STAT3 transcriptional activity and selectivity against STAT1. The cytotoxicity of each compound was tested after 24, 72 and 120 h of cell culture using a trypan blue exclusion assay or a viability test based on tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT).</ce:para>
                     <ce:para id="p0070" view="all">As a methyl on a phenyl moiety is quickly metabolized, a significant amount of work has been done to substitute this group (R<ce:inf loc="post">1</ce:inf> substituent, <ce:cross-ref refid="tbl1" id="crosref0150">Table 1.1</ce:cross-ref>). Electron donating group (<ce:bold>14</ce:bold>) and hydrophilic groups (<ce:bold>20</ce:bold>, <ce:bold>21</ce:bold>) reduced activity on STAT3 while small electron withdrawing groups retained or increased activity and selectivity against STAT1 (<ce:bold>11</ce:bold>, <ce:bold>12</ce:bold>, <ce:bold>16</ce:bold>, <ce:bold>23</ce:bold>). Among those, the nitro group at the <ce:italic>para</ce:italic> position (<ce:bold>23</ce:bold>) led to an effective STAT3 inhibition and enhanced selectivity. The optimal position of the nitro substituent has been confirmed to be the <ce:italic>para</ce:italic> position (<ce:bold>24</ce:bold>, <ce:bold>25</ce:bold>). An additional nitro group did not improve the inhibitory activity (<ce:bold>26</ce:bold>), however an additional alkoxy substituent on the benzyl moiety (<ce:cross-ref refid="tbl1" id="crosref0155">Table 1.2</ce:cross-ref>) leads to increase of activity depending on the size of substituent. This last series of compounds led to the identification of compound <ce:bold>30</ce:bold>, which was endowed with high activity but lacked selectivity against STAT1. We also synthesized and tested a series of cycles and heterocycles fused or linked to the benzyl moiety without any convincing result (<ce:cross-ref refid="appsec1" id="crosref0160">Table S1</ce:cross-ref>).</ce:para>
                     <ce:para id="p0075" view="all">The methoxy group appeared to be the optimal R<ce:inf loc="post">2</ce:inf> substituent, which cannot be removed or replaced (<ce:cross-ref refid="tbl1" id="crosref0165">Tables 1.3 and 1.4</ce:cross-ref>). In the R<ce:inf loc="post">1</ce:inf> = 4-CH<ce:inf loc="post">3</ce:inf> series, the activity on STAT3 was enhanced by modulating the hydrophobicity of the halogen (<ce:cross-ref refid="tbl1" id="crosref0170">Table 1.5</ce:cross-ref>). Bromine at R<ce:inf loc="post">3</ce:inf> seems the best compromise between potency and selectivity but this was not reproducible in the nitro series (<ce:cross-ref refid="tbl1" id="crosref0175">Table 1.6</ce:cross-ref>).</ce:para>
                  </ce:section>
                  <ce:section id="sec2.4" view="all">
                     <ce:label>2.4</ce:label>
                     <ce:section-title id="sectitle0060">Importance of the aminotetrazole group</ce:section-title>
                     <ce:para id="p0080" view="all">Variations based on the partial or complete modification of the aminotetrazole group were set up to characterize the involvement of each parameter in inhibition and selectivity (<ce:cross-ref refid="tbl1" id="crosref0180">Tables 1.7 and 1.8</ce:cross-ref>). The importance of the secondary amine was shown by the reduced activity of the methylene derivative <ce:bold>44</ce:bold>. Replacing the tetrazole of <ce:bold>5</ce:bold> with a carboxylic acid in <ce:bold>45</ce:bold> significantly reduced both STAT3 and STAT1 inhibition. Interestingly, non ionizable aldehyde and cyanamide derivatives that share a planar structure displayed the same range of inhibition as the tetrazole analogs. Among the R<ce:inf loc="post">1</ce:inf> = 4-CH<ce:inf loc="post">3</ce:inf> series, the cyanamide <ce:bold>43</ce:bold> and the aldehyde <ce:bold>42</ce:bold> were both able to inhibit STAT3 transcriptional activity. These experiments suggest that the planar structure of the hydrophilic part of inhibitors is crucial for STAT3 binding. Indeed, the compounds <ce:bold>42</ce:bold> and <ce:bold>43</ce:bold> were able to inhibit STAT1 activity whereas their tetrazole analog (<ce:bold>5</ce:bold>) exhibited reduced activity on STAT1 suggesting that a negative charge on the tetrazole moiety is implied in selectivity. This experiment has been reproduced in the R<ce:inf loc="post">1</ce:inf> = 4-NO<ce:inf loc="post">2</ce:inf> series (<ce:cross-ref refid="tbl1" id="crosref0185">Table 1.2</ce:cross-ref>) in which, all compounds except tetrazole analog <ce:bold>23</ce:bold> showed STAT3 and STAT1 inhibitory functions, while <ce:bold>23</ce:bold> is the only compound with low activity on STAT1. We also tested a series of compounds with two acidic functions without convincing results (<ce:cross-ref refid="appsec1" id="crosref0190">Table S2</ce:cross-ref>).</ce:para>
                     <ce:para id="p0085" view="all">The role of the aminotetrazole group in binding to the STAT3 SH2 domain was confirmed by <ce:italic>in silico</ce:italic> molecular modeling. Atomistic molecular dynamics simulations were performed to sample the general dynamics of human STAT3 at a time scale of ∼60 ns. This provides a reliable basis for ensemble docking studies of two series of inhibitors: R<ce:inf loc="post">1</ce:inf> = 4-NO<ce:inf loc="post">2</ce:inf> series (<ce:bold>23</ce:bold>, <ce:bold>45</ce:bold>, <ce:bold>46</ce:bold>, <ce:bold>49</ce:bold>) and R<ce:inf loc="post">1</ce:inf> = 4-CH<ce:inf loc="post">3</ce:inf> series (<ce:bold>5</ce:bold>, <ce:bold>35</ce:bold>, <ce:bold>42</ce:bold>, <ce:bold>43</ce:bold>). The distributions of the best predicted binding scores of these inhibitors to dimerization interface of STAT3 SH2 domain obtained for 200 representative protein structures from molecular dynamics simulations are shown in <ce:cross-ref refid="fig4" id="crosref0195">Fig. 4</ce:cross-ref>
                        <ce:float-anchor refid="fig4"/></ce:float-anchor>.</ce:para>
                     <ce:para id="p0090" view="all">It is clearly seen that the inhibitors containing the tetrazole group (<ce:bold>5</ce:bold>, <ce:bold>23</ce:bold>, and <ce:bold>35</ce:bold>) show much stronger binding energies than the inhibitors, which lack this group. The peaks of energy distributions for <ce:bold>5</ce:bold>, <ce:bold>23</ce:bold> and <ce:bold>35</ce:bold> are similar and located near −6 kcal/mol. In contrast, the peaks for other inhibitors are between −5.5 and −5 kcal/mol. This result clearly shows that the tetrazole group is important for strong binding of the inhibitors to the dimerization interface of the STAT3 SH2 domain, which seems to be necessary for the effective inhibition of its activity.</ce:para>
                     <ce:para id="p0095" view="all">The ability of these pharmacological agents to physically bind to the STAT3 SH2 domain was further assessed at the molecular level using a fluorescence-based competition assay. The binding affinity to STAT3 (<ce:cross-ref refid="fig5" id="crosref0200">Fig. 5</ce:cross-ref>
                        <ce:float-anchor refid="fig5"/></ce:float-anchor>A) of compounds belonging to the nitro series is improved compared to the methyl series. Compound <ce:bold>45</ce:bold> is a special case, however <ce:bold>45</ce:bold> is the carboxylic acid bioisoster of <ce:bold>23</ce:bold> and does not bind to STAT3. This result supports our hypothesis that the planar structure is crucial for STAT3 binding. Thus all compounds with a planar hydrophilic part including aminotetrazole exhibit a similar binding capacity on STAT3 monomers. The binding was also assessed using STAT1 monomers (<ce:cross-ref refid="fig5" id="crosref0205">Fig. 5</ce:cross-ref>B). While the binding affinity of <ce:bold>5</ce:bold> and <ce:bold>23</ce:bold> bearing the aminotetrazole function were significantly reduced, other compounds retained the ability to bind STAT1. These results showed that the presence of the aminotetrazole group prevents the ability of <ce:bold>5</ce:bold> and <ce:bold>23</ce:bold> to interact with STAT1.</ce:para>
                  </ce:section>
                  <ce:section id="sec2.5" view="all">
                     <ce:label>2.5</ce:label>
                     <ce:section-title id="sectitle0065">Biological assessment of compound 23</ce:section-title>
                     <ce:para id="p0100" view="all">Compound <ce:bold>23</ce:bold>, which includes a nitro group on the phenyl moiety and an aminotetrazole on the hydrophilic part, was selected as the best candidate to inhibit STAT3 transcriptional activity in a dose dependent manner (<ce:cross-ref refid="fig6" id="crosref0210">Fig. 6</ce:cross-ref>
                        <ce:float-anchor refid="fig6"/></ce:float-anchor>A) and its pharmacological profile was further explored.</ce:para>
                     <ce:para id="p0105" view="all">The IC<ce:inf loc="post">50</ce:inf> of <ce:bold>23</ce:bold> as determined with regard to its ability to block the luciferase activity induced by STAT3 activators was 25.7 ± 2.6 μM. The potency of <ce:bold>23</ce:bold> to prevent phospho-STAT3 translocation into the nuclear compartment was evaluated on HeLa and B9 cells after treatment with Oncostatin M. Accumulation of STAT3 in the cytoplasm and decrease of phospho-STAT3 in the nucleus was observed by western blot (<ce:cross-ref refid="fig6" id="crosref0215">Fig. 6</ce:cross-ref>B) and confocal microscopy imaging (<ce:cross-ref refid="fig6" id="crosref0220">Fig. 6</ce:cross-ref>C). This confirmed that <ce:bold>23</ce:bold> is able to bind STAT3 and to prevent its nuclear translocation.</ce:para>
                     <ce:para id="p0110" view="all">The biological activity of <ce:bold>23</ce:bold> was assessed on several cell lines. <ce:bold>23</ce:bold> decreased proliferation of B9 myeloma cell line, for which growth depends on IL6/STAT3 signaling pathway, and a breast cancer cell line MDA-MB-231, which expresses activated STAT3, in a dose dependent manner (<ce:cross-ref refid="fig7" id="crosref0225">Fig. 7</ce:cross-ref>
                        <ce:float-anchor refid="fig7"/></ce:float-anchor>A). To prove the role of <ce:bold>23</ce:bold> in inhibiting STAT3 dimerization, the MDA-MB-231 cells were transfected with STAT3-C, a genetically engineered mutant of STAT3 that forms a constitutively dimerized STAT3 <ce:cross-ref refid="bib16" id="crosref0230">[16]</ce:cross-ref> through disulfide bonds in the absence of tyrosine phosphorylation and treated with compound <ce:bold>23</ce:bold>. Viability and proliferation assays have shown that <ce:bold>23</ce:bold> had no inhibitory effect on proliferation of MDA-MB-231, which express STAT3-C. These results suggest that compound <ce:bold>23</ce:bold> specifically target STAT3 monomers and prevents its dimerization.</ce:para>
                     <ce:para id="p0115" view="all">We have previously shown that STAT3 prevents the expression of Natural Killer cell lymphocyte (NK) activating ligand in HT-29 cells <ce:cross-ref refid="bib17" id="crosref0235">[17]</ce:cross-ref>. Accordingly, we investigated the ability of <ce:bold>23</ce:bold> to modulate the activation of NK in cocultures with HT-29 cells. Similarly to STA21, <ce:bold>23</ce:bold> was able to promote HT-29 recognition and IFN-γ production by NK at 50 μM (<ce:cross-ref refid="fig7" id="crosref0240">Fig. 7</ce:cross-ref>B).</ce:para>
                     <ce:para id="p0120" view="all">The involvement of STAT3 in the differentiation of CD4<ce:sup loc="post">+</ce:sup> T lymphocytes is another known role of this transcription factor <ce:cross-ref refid="bib18" id="crosref0245">[18]</ce:cross-ref>. STAT3 contributes to the polarization of CD4<ce:sup loc="post">+</ce:sup> T lymphocytes into Th17, Treg lymphocytes but has no effect on Th1 polarization. Thus, the influence of <ce:bold>23</ce:bold> on the polarization of naïve CD4+ T cells in Th17 or Th1 was tested. After exposure to 50 μM <ce:bold>23</ce:bold>, as well as STA21, the transcription of ROR-γt and FoxP3 were decreased when naïve CD4<ce:sup loc="post">+</ce:sup> T cells were differentiated towards Th17 or Treg lymphocytes. In contrast, <ce:bold>23</ce:bold> did not affect the transcription of Tbet during Th1 differentiation (<ce:cross-ref refid="fig7" id="crosref0250">Fig. 7</ce:cross-ref>C).</ce:para>
                     <ce:para id="p0125" view="all">Altogether our results show that <ce:bold>23</ce:bold> is a selective pharmacological inhibitor of STAT3, which prevents STAT3 transcriptional activity directly in several biological assays.</ce:para>
                  </ce:section>
               </ce:section>
               <ce:section id="sec3" role="discussion" view="all">
                  <ce:label>3</ce:label>
                  <ce:section-title id="sectitle0070">Discussion</ce:section-title>
                  <ce:para id="p0130" view="all">A structure-based virtual screening approach followed by medicinal chemistry optimization has been used to identify a novel series of Stat3 inhibitors. First, virtual screening was utilized to select non-peptide commercially available compounds able to mimic the phosphotyrosine peptide co-crystallized with the Stat3β SH2 domain (<ce:cross-ref refid="fig1" id="crosref0255">Fig. 1</ce:cross-ref>).</ce:para>
                  <ce:para id="p0135" view="all">Their evaluation by a Stat3-dependent luciferase reporter (<ce:cross-ref refid="fig2" id="crosref0260">Fig. 2</ce:cross-ref>A) then led to the identification of compound <ce:bold>5</ce:bold> as the most promising candidate. An extensive set of derivatives was synthesized (<ce:cross-ref refid="fig3" id="crosref0265">Fig. 3</ce:cross-ref> and <ce:cross-ref refid="tbl1" id="crosref0270">Table 1</ce:cross-ref>) and subjected to an <ce:italic>in vitro</ce:italic> luciferase gene reporter assay. This led to identification of <ce:bold>23</ce:bold>, a new pharmacological agent devoid of inhibitory activity on STAT1 but blocking STAT3 transcriptional activity with an IC<ce:inf loc="post">50</ce:inf> of 25.7 μM.</ce:para>
                  <ce:para id="p0140" view="all">Compound <ce:bold>23</ce:bold> Stat3 inhibitory activity is similar to that described for STA21 <ce:cross-ref refid="bib15" id="crosref0275">[15]</ce:cross-ref>, a natural inhibitor of complex chemical structure, whose chemical modification is cumbersome <ce:cross-ref refid="bib19" id="crosref0280">[19]</ce:cross-ref>. Niclosamide, a known anthelmintic <ce:cross-ref refid="bib20" id="crosref0285">[20]</ce:cross-ref>, is actually one of the best small molecule inhibitors of STAT3. It inhibits STAT3-mediated luciferase reporter activity at submicromolar concentrations but no structure activity relationships have ever been established for this compound. The same applies to HJC0123 <ce:cross-ref refid="bib21" id="crosref0290">[21]</ce:cross-ref>, which displays inhibitory properties at 5 μM. Stattic <ce:cross-ref refid="bib22" id="crosref0295">[22]</ce:cross-ref> displays a very high affinity in a fluorescence polarization-based binding assay but seems to bind irreversibly to STAT3. Celecoxib <ce:cross-ref refid="bib23" id="crosref0300">[23]</ce:cross-ref>, SI31–V3-32 <ce:cross-ref refid="bib24" id="crosref0305">[24]</ce:cross-ref>, STX-0119 <ce:cross-ref refid="bib25" id="crosref0310">[25]</ce:cross-ref> and isophtalate derivatives <ce:cross-ref refid="bib26" id="crosref0315">[26]</ce:cross-ref> seem to be in the same range of activity as <ce:bold>23</ce:bold>, while LY5 <ce:cross-ref refid="bib27" id="crosref0320">[27]</ce:cross-ref>, phenylquinoline derivatives <ce:cross-ref refid="bib28" id="crosref0325">[28]</ce:cross-ref>, benzothiazole analogues <ce:cross-ref refid="bib29" id="crosref0330">[29]</ce:cross-ref> and 4-aminophenol derivatives <ce:cross-ref refid="bib30" id="crosref0335">[30]</ce:cross-ref> displayed better results than <ce:bold>23</ce:bold>. The development of STAT3 inhibitor S3I-201 <ce:cross-ref refid="bib31" id="crosref0340">[31]</ce:cross-ref> opened the studies of salicylic derivatives <ce:cross-refs refid="bib32e bib32 bib32a bib32b bib32c bib32d" id="crosrefs0030">[32]</ce:cross-refs> that bind to the STAT3 SH2 domain. Further development led to BP-1-102 <ce:cross-refs refid="bib33b bib33 bib33a" id="crosrefs0035">[33]</ce:cross-refs> exhibiting 30–40% inhibition at a concentration of 15 μM in a STAT3 luciferase reporter assay.</ce:para>
                  <ce:para id="p0145" view="all">Compound <ce:bold>23</ce:bold> shows a moderate activity in comparison to some of the above-mentioned compounds but it benefits from extensive structure function studies, which identified an important role of the aminotetrazole group in modulating relative STAT1 and STAT3 inhibitory activities. Tetrazole substitution by aldehyde, cyanamide or carboxylic acid in the parent <ce:bold>5</ce:bold> structure (<ce:cross-ref refid="tbl1" id="crosref0345">Table 1.7</ce:cross-ref>) hampered the selectivity against STAT1. Similar results were achieved using <ce:bold>23</ce:bold> series (<ce:cross-ref refid="tbl1" id="crosref0350">Table 1.8</ce:cross-ref>). The influence of the tetrazole moiety was also confirmed in numerical simulations involving molecular dynamic and ensemble docking studies (<ce:cross-ref refid="fig4" id="crosref0355">Fig. 4</ce:cross-ref>). Finally, inhibition of binding of fluorescein-labeled phosphopeptides, which bind to the SH2 domains of STAT3 (<ce:cross-ref refid="fig5" id="crosref0360">Fig. 5</ce:cross-ref>) suggests that selectivity appears to be at a molecular level.</ce:para>
                  <ce:para id="p0150" view="all">For the last ten years, several chemical groups that target the pTyr subpocket in the SH2 domain have been identified including phosphate esters <ce:cross-refs refid="bib34d bib34e bib34f bib34 bib34a bib34b bib34c" id="crosrefs0040">[34]</ce:cross-refs>, catechol <ce:cross-ref refid="bib32b" id="crosref0365">[32b]</ce:cross-ref>, salicylic <ce:cross-refs refid="bib32e bib32 bib32a bib32b bib32c bib32d" id="crosrefs0045">[32]</ce:cross-refs>, isophtalate <ce:cross-ref refid="bib26" id="crosref0370">[26]</ce:cross-ref> carboxylate <ce:cross-ref refid="bib25" id="crosref0375">[25]</ce:cross-ref> and sulfamide <ce:cross-ref refid="bib24" id="crosref0380">[24]</ce:cross-ref>. An affinity of the aminotetrazole group to the dimerization interface of STAT3 SH2 domain adds to this list and could be advantageous in the design of future inhibitors.</ce:para>
                  <ce:para id="p0155" view="all">The proliferating and transcriptional activity of <ce:bold>23</ce:bold> has been established (<ce:cross-ref refid="fig7" id="crosref0385">Fig. 7</ce:cross-ref>). <ce:bold>23</ce:bold> significantly inhibits the growth and survival of the cells with normal Stat3 signaling pathway but has a minimal effect on the cells lacking this pathway. Compound <ce:bold>23</ce:bold> promotes an expression of NK activating ligands on a HT-29 – NK coculture. Moreover, <ce:bold>23</ce:bold> prevents CD4<ce:sup loc="post">+</ce:sup> differentiation towards Th17 and Treg lymphocytes but did not affect their differentiation into Th1 lymphocytes. Compound <ce:bold>23</ce:bold> is therefore a novel and selective pharmacological inhibitor of STAT3, which affects most of its biological functions.</ce:para>
                  <ce:para id="p0160" view="all">IFNγ was the first cytokine shown to activate STAT1 signaling <ce:cross-refs refid="bib35b bib35 bib35a" id="crosrefs0050">[35]</ce:cross-refs> and STAT1 has been shown to mediate the anti-proliferative activity of IFNs <ce:cross-ref refid="bib36" id="crosref0390">[36]</ce:cross-ref>. STAT1 has been suggested to have tumor-suppressor properties <ce:cross-ref refid="bib37" id="crosref0395">[37]</ce:cross-ref> and expression of STAT1 suppressed the tumorigenicity of RAD-105 cells <ce:italic>in vivo</ce:italic>, which correlated with a decreased expression of proangiogenic molecules such as bFGF, MMP-2, and MMP-9 <ce:cross-ref refid="bib38" id="crosref0400">[38]</ce:cross-ref>. Although the role of STAT1 in tumorigenesis appears to be complex, these findings demonstrate that STAT1 can act as an inhibitor of tumor progression by restraining tumor growth and metastasis. During recent years, it has been clearly established that the JAK-STAT3 pathway activation is important for the progression of cancer. However, targeting growth factors such as IL-6 might be inefficient for cancer therapy since multiple signaling pathways induce STAT3 transcriptional activity. Then, the development of small-pharmacological agents to directly and selectively target STAT3 might be a promising way to target inflammation or tumor development.</ce:para>
               </ce:section>
               <ce:section id="sec4" view="all">
                  <ce:label>4</ce:label>
                  <ce:section-title id="sectitle0075">Experimental section</ce:section-title>
                  <ce:section id="sec4.1" view="all">
                     <ce:label>4.1</ce:label>
                     <ce:section-title id="sectitle0080">Computational chemistry</ce:section-title>
                     <ce:section id="sec4.1.1" view="all">
                        <ce:label>4.1.1</ce:label>
                        <ce:section-title id="sectitle0085">Screening compounds collection</ce:section-title>
                        <ce:para id="p0165" view="all">An in-house collection of commercially-available compounds <ce:cross-ref refid="bib10" id="crosref0405">[10]</ce:cross-ref> was set-up by gathering 2D structures from 21 suppliers and post-processing all structures in a customized PipelinePilot <ce:cross-ref refid="bib39" id="crosref0410">[39]</ce:cross-ref> protocol for (i) cleaning input files (removing salts, duplicates and unwanted compounds, e.g. molecules with more than 2 implicit stereocenters); (ii) filtering by drug-likeness and ionizing at pH 7.4 with Filter <ce:cross-ref refid="bib40" id="crosref0415">[40]</ce:cross-ref>; (iii) homogenizing the structures with the ChemAxon standardizer tool <ce:cross-ref refid="bib41" id="crosref0420">[41]</ce:cross-ref>. The Bioinfo-DB database in its 2009 release contained a total of 3,119,634 unique compounds out of which a subset of 78,119 molecules containing at least one negative ionizable group was extracted. All structures were then converted in 3D coordinates using Corina <ce:cross-ref refid="bib41" id="crosref0425">[41]</ce:cross-ref> allowing a maximum of four stereoisomers by racemic structure. A final set of 104,581 unique 3D ligand structures was retained for docking.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.2" view="all">
                        <ce:label>4.1.2</ce:label>
                        <ce:section-title id="sectitle0090">Virtual screening</ce:section-title>
                        <ce:para id="p0170" view="all">The biological assembly of mouse Stat3 DNA-bound hererodimeric structure <ce:cross-ref refid="bib11" id="crosref0430">[11]</ce:cross-ref> was extracted from the Protein Data Bank (PDB identifier 1BG1). The phosphorylated ligand was defined as the C-terminal Ala<ce:sup loc="post">703</ce:sup>-Pro<ce:sup loc="post">704</ce:sup>-pTyr<ce:sup loc="post">705</ce:sup>-Leu<ce:sup loc="post">706</ce:sup>-Lys<ce:sup loc="post">707</ce:sup> sequence of the Stat3 monomer B whereas its SH2 binding site was defined by any residue of monomer A having at least one heavy atom in a 12.5 Å-sphere radius centered on pTyr<ce:sup loc="post">705</ce:sup> of the Stat3 chain B. After removing the DNA atoms, hydrogen atoms were added to all residues of both chains thanks to the Biopolymer module of the SYBYL package <ce:cross-ref refid="bib42" id="crosref0435">[42]</ce:cross-ref>. Ionization and tautomeric states of Stat3 residues in the pTyr-binding site was defined manually in order to optimize the intermolecular hydrogen bond network between the two Stat3 chains. Chain B was then removed and atomic coordinates of chain A saved for docking. Docking of the filtered set of the BioinfoDB database was done using standard “speed1 settings” of the PLANTS docking program <ce:cross-ref refid="bib43" id="crosref0440">[43]</ce:cross-ref> and the Chemplp scoring function.</ce:para>
                        <ce:para id="p0175" view="all">Hit selection was based on a two-step knowledge-based protocol aimed at identifying compounds that share phosphorylated peptide key interactions with key residues of Stat3. For this purpose, all docking poses were converted into 1D protein-ligand interaction fingerprints (IFP) using the in-house developed IFP program <ce:cross-ref refid="bib12" id="crosref0445">[12]</ce:cross-ref>. A first reference IFP (IFP1: 4 bits/residue) was defined between pTyr705 (Stat3 B chain) and its anchoring residues (Lys591, Arg609) in chain A, considering polar interactions only (hydrogen bonds and salt bridges). A second IFP (IFP2: 7 bits/residue) was then defined between the phosphorylated peptide Ala<ce:sup loc="post">703</ce:sup>-Pro<ce:sup loc="post">704</ce:sup>-pTyr<ce:sup loc="post">705</ce:sup>-Leu<ce:sup loc="post">706</ce:sup>-Lys<ce:sup loc="post">707</ce:sup> of chain B and its full binding site (Lys591, Arg595, Arg609, Ser611, Ser613, Ser614, Thr620, Phe621, Trp623, Lys626, Ile634, Gln635, Ser636, Val637, Glu638, Pro639, Tyr640, Tyr657, Ile659, Cys712, Val713, Thr714, Pro715, Phe716) in chain A considering all interactions (hydrophobic, aromatic, hydrogen bonds and salt bridges) <ce:cross-ref refid="bib12" id="crosref0450">[12]</ce:cross-ref>. Tanimoto coefficients were then computed between the interaction fingerprints of all BioinfoDB docking poses and each of the two reference IFPs. Poses with a Tanimoto coefficient of 1.0 (IFP1) and higher than 0.5 (IFP2) were selected next, leaving a final set of 52 non-redundant hits.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.1.3" view="all">
                        <ce:label>4.1.3</ce:label>
                        <ce:section-title id="sectitle0095">Molecular dynamics simulations and ensemble docking</ce:section-title>
                        <ce:para id="p0180" view="all">The structure of human STAT3 monomer was constructed by homology modeling using the full-length sequence and the human STAT1 crystal structure 1BF5 as a template. The homology modeling was performed with the SWISS- MODEL server <ce:cross-ref refid="bib44" id="crosref0455">[44]</ce:cross-ref>. The model obtained was subject to all-atom molecular dynamics simulations in water in the NPT ensemble at a temperature of 300 K and a pressure of 1 atm. GROMACS 4.6.5 software suit with GROMOS 54A7force field was used. The protein was energy minimized and subject to 20 ns simulation with restrained backbone followed by unrestrained 60 ns production simulation. The equilibration was monitored by the RMSD of Ca atoms. The last 10 ns of the trajectory were used to extract 200 frames at 5 ps intervals. These frames were used as the representative structures in ensemble docking simulations.</ce:para>
                        <ce:para id="p0185" view="all">The docking procedure was performed as follows. The structures of selected inhibitors were optimized using Gaussian09 at the B3LYP/6–31++G(d) level of theory and their ESP partial charged were computed. The ligands and the corresponding protein structures were prepared for docking using the MGLTools-1.5.6. The docking was performed with the Autodock Vina <ce:cross-ref refid="bib45" id="crosref0460">[45]</ce:cross-ref>. Analysis of the docking results was performed with custom software based on the Python binding of the Pteros molecular modeling library <ce:cross-ref refid="bib46" id="crosref0465">[46]</ce:cross-ref>.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.2" view="all">
                     <ce:label>4.2</ce:label>
                     <ce:section-title id="sectitle0100">STAT inhibitors synthesis</ce:section-title>
                     <ce:para id="p0190" view="all">Starting material reagents and analytical grade solvents were purchased from Sigma–Aldrich and Acros. All reactions were routinely checked by TLC using Merck Kieselgel 60 F254 aluminum plates and visualized by UV light. IR spectra were performed on a Spectrum65 perkin Elmer with UATR and principal absorptions are given in cm-1. <ce:sup loc="pre">1</ce:sup>H and <ce:sup loc="pre">13</ce:sup>C NMR spectra were recorded in the specified deuterated solvent at 300 MHz and 75 MHz on a Brucker AC 300 instrument. Chemical shifts are expressed in parts per million (<ce:italic>δ</ce:italic>) relative to the solvent signal and the coupling constants J are given in Hertz (Hz). ESI – MS analyses were carried out at the Service Commun d'Analyse, ICMR – UMR CNRS 6229–51,100 Reims.</ce:para>
                     <ce:section id="sec4.2.1" view="all">
                        <ce:label>4.2.1</ce:label>
                        <ce:section-title id="sectitle0105">3-chloro-5-methoxy-4-(4-methylbenzyloxy)benzaldehyde 42</ce:section-title>
                        <ce:para id="p0195" view="all">The 4-methylbenzyl chloride (540 mg, 3.84 mmol) was added to a suspension of the 5-chlorovanilline (596 mg, 3.20 mmol), sodium iodide (1.153 g, 7.69 10<ce:sup loc="post">−3</ce:sup> mol) and sodium carbonate (815 mg, 8.3 mmol) in dry acetone. The reaction mixture was stirred to reflux. Overnight and then it was diluted with water and extracted three times with ethylacetate. The combined organic layer was washed with brine, dried over sodium sulfate, filtered and evaporated under vacuum. The product was obtained by flash chromatography (cyclohexane – dichloromethane: 4–6) as a white solid (788 mg, 85%). IR (ATR): 3051, 3026, 2920, 2838, 2741, 1691, 1589, 1572 cm<ce:sup loc="post">−1</ce:sup>. 1H NMR (300 MHz, <ce:italic>CDCl</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>3</ce:italic>
                           </ce:inf>) ppm 9.83 (s, 1H), 7.48 (s, 1H), 7.39 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>7.7 Hz, 2H), 7.35 (s, 1H), 7.17 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>7.7 Hz, 2H), 5.13 (s, 2H), 3.93 (s, 3H), 2.35 (s, 3H). 13C NMR (75 MHz, <ce:italic>CDCl</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>3</ce:italic>
                           </ce:inf>) ppm 189.9, 154.5, 149.6, 138.1, 133.5, 132.4, 129.3, 129.0, 128.6, 125.8, 109.4, 75.0, 56.2, 21.2.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.2" view="all">
                        <ce:label>4.2.2</ce:label>
                        <ce:section-title id="sectitle0110">N-(3-chloro-5-methoxy-4-(4-methylbenzyloxy)benzyl)-2H-tetrazole-5-amine 5</ce:section-title>
                        <ce:para id="p0200" view="all">A solution of <ce:bold>42</ce:bold> (154 mg, 0.53 mmol) and 5-aminotetrazole (90 mg, 0.11 mmol) in a mixture of methanol and dichloromethane (a suspension was prepared in methanol and dichloromethane was added until dissolution) was stirred at rt for 2 h. Then sodium cyanoborohydride (40 mg, 0.64 mmol) was added and the reaction mixture was further stirred overnight. The reaction was quenched with water. The product was extracted with ethylacetate. The combined organic layers were washed with brine and dried over sodium sulfate. The product was obtained by column chromatography (dichloromethane – methanol: 95-5) as a white solid (76 mg, 40%). IR (ATR): 3253, 3146, 3051, 2923, 2880, 1624, 1578, 1537, 1518 cm<ce:sup loc="post">−1</ce:sup>. 1H NMR (300 MHz, <ce:italic>DMSO D</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>6</ce:italic>
                           </ce:inf>) ppm 14.65 (s, 1H), 7.53 (t, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>6.2 Hz, 1H), 7.34 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>7.8 Hz, 2H), 7.18 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>7.8 Hz, 2H), 7.05 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>1.1 Hz, 1H), 6.98 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>1.1 Hz, 1H), 4.90 (s, 2H), 4.34 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>6.2 Hz, 2H), 3.84 (s, 3H), 2.31 (s, 3H). 1H NMR (300 MHz, <ce:italic>DMSO D</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>6</ce:italic>
                           </ce:inf>) ppm 153.4, 152.1, 142.2, 137.1, 136.1, 133.9, 128.6, 128.2, 126.7, 119.7, 110.9, 73.9, 56.0, 46.1, 20.7. HRMS (ESI) calcd for C<ce:inf loc="post">17</ce:inf>H<ce:inf loc="post">18</ce:inf>ClN<ce:inf loc="post">5</ce:inf>O<ce:inf loc="post">2</ce:inf>Na 382.1047 [(M + Na)<ce:sup loc="post">+</ce:sup>]; found 382.1053.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.3" view="all">
                        <ce:label>4.2.3</ce:label>
                        <ce:section-title id="sectitle0115">3-chloro-5-methoxy-4-(4-nitrobenzyloxy)benzaldehyde 46</ce:section-title>
                        <ce:para id="p0205" view="all">The 4-nitrobenzyl bromide (1.19 g, 5.51 mmol) was added to a suspension of the 5-chlorovanilline (1.03 g, 5.51 mmol), and sodium carbonate (876 mg, 8.3 mmol) in dry DMF. The reaction mixture was stirred at rt overnight and then it was diluted with water and extracted three times with ethylacetate. The combined organic layer was washed with brine, dried over with sodium sulfate, filtered and evaporated under vacuum. The product was obtained by recrystallization (cyclohexane – dichloromethane: 4–6) as a white fluffy solid (1.5 g, 84%). IR (ATR): 3107, 3085, 3008, 2950, 2868, 1697, 1606, 1593, 1574, 1517 cm<ce:sup loc="post">−1</ce:sup>. 1H NMR (300 MHz, <ce:italic>DMSO D</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>6</ce:italic>
                           </ce:inf>) <ce:italic>δ</ce:italic> ppm 9.91 (s, 1H), 8.27 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>7.2 Hz, 2H), 7.78 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>7.2 Hz, 2H), 7.68 (s, 1H), 7.56 (s, 1H), 5.30 (s, 2H), 3.95 (s, 3H). 13C NMR (75 MHz, <ce:italic>DMSO D</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>6</ce:italic>
                           </ce:inf>) 191.0, 153.8, 148.0, 147.1, 144.3, 132.7, 128.7, 127.6, 124.0, 123.4, 111.0, 73.0, 56.4.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.2.4" view="all">
                        <ce:label>4.2.4</ce:label>
                        <ce:section-title id="sectitle0120">N-(3-chloro-5-methoxy-4-(4-nitrobenzyloxy)benzyl)-2H-tetrazole-5-amine 23</ce:section-title>
                        <ce:para id="p0210" view="all">A solution of <ce:bold>46</ce:bold> (1.03 g, 3.20 mmol) and 5-aminotetrazole (545 mg, 6.41 mmol) in a mixture of methanol and dichloromethane (a suspension was prepared in methanol and dichloromethane was added until dissolution) was stirred at r.t. for 2 h. Then sodium cyanoborohydride (242 mg, 3.84 mmol) was added and the reaction mixture was further stirred overnight. The reaction was quenched with water. The product was extracted with ethylacetate. The combined organic layers were washed with brine and dried over with sodium sulfate. The solvent was removed in vacuum and the product was obtained by recrystallization (cyclohexane – dichloromethane:4–6) as a white solid (700 mg, 56%). IR (ATR): 3274, 3161, 3076, 2940, 2885, 2850, 2779, 2694, 1643, 1602, 1578, 1523 cm<ce:sup loc="post">−1</ce:sup>. 1H NMR (300 MHz, <ce:italic>DMSO D</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>6</ce:italic>
                           </ce:inf>) <ce:italic>δ</ce:italic> ppm 14.69 (s, 1H), 8.26 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>8.5 Hz, 2H), 7.76 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>8.5 Hz, 2H), 7.58 (s, 1H), 7.09 (s, 1H), 7.01 (s, 1H), 5.11 (s, 2H), 4.35 (d, <ce:italic>J</ce:italic>
                           <ce:hsp sp="0.2"/></ce:hsp>=<ce:hsp sp="0.2"/></ce:hsp>4.3 Hz, 2H), 3.83 (s, 3H). 13C NMR (75 MHz, <ce:italic>DMSO D</ce:italic>
                           <ce:inf loc="post">
                              <ce:italic>6</ce:italic>
                           </ce:inf>) <ce:italic>δ</ce:italic> ppm 153.3, 148.9, 147.0, 144.8, 142.0, 136.6, 128.6, 126.6, 123.4, 119.7, 111.0, 72.8, 56.1, 46.1. HRMS (ESI) calcd for C<ce:inf loc="post">16</ce:inf>H<ce:inf loc="post">16</ce:inf>ClN<ce:inf loc="post">6</ce:inf>O<ce:inf loc="post">4</ce:inf> 391.0922 [(M + H)<ce:sup loc="post">+</ce:sup>]; found 391.0918.</ce:para>
                     </ce:section>
                  </ce:section>
                  <ce:section id="sec4.3" view="all">
                     <ce:label>4.3</ce:label>
                     <ce:section-title id="sectitle0125">Biological assays</ce:section-title>
                     <ce:section id="sec4.3.1" view="all">
                        <ce:label>4.3.1</ce:label>
                        <ce:section-title id="sectitle0130">Cells and reagents</ce:section-title>
                        <ce:para id="p0215" view="all">Human breast cancer (MDA-MB-231) and colorectal adenocarcinoma cell line (HT-29) were obtained from ATCC (the American Type Culture Collection, Manassas, VA, USA).</ce:para>
                        <ce:para id="p0220" view="all">HeLa/STAT3-luc cell line, containing a promoter with STAT3 element responses controlling the luciferase gene, was obtained from Panomics (Redwood city, CA, USA). HeLa/STAT3-Luc cell line was cultured with hygromycin selection (500 μg/mL). Expositions of this cell line to Oncostatin M enabled the induction of luciferase activity.</ce:para>
                        <ce:para id="p0225" view="all">Cells were grown in Dulbeccos's Modified Eagles Medium (Gibco-BRL, France), supplemented with 50 U/ml penicillin, 50 μg/ml streptomycin, 2 mM L-glutamine, 1 mM Na pyruvate (Gibco-BRL, France) and 10% decomplemented fetal calf serum (Seromed, France).</ce:para>
                        <ce:para id="p0230" view="all">The mouse B cell hybridoma B9, known to proliferate in a interleukin 6 (IL-6) dependent manner, was maintained in RPMI 1640 complemented with 2 mM Glutamine, 50 μM 2-Mercaptoethanol (2 ME), 50 pg/ml recombinant human IL-6 (Peprotech, France).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.2" view="all">
                        <ce:label>4.3.2</ce:label>
                        <ce:section-title id="sectitle0135">Generation of reporter cell lines</ce:section-title>
                        <ce:para id="p0235" view="all">The STAT1 reporter 8x-GAS-Luc plasmid was obtained by Dr C. K. Glass, (Department of Medicine, University of California, San Diego, CA, U.S.A.) The plasmid DNA was transfected into cervical epithelial HeLa cells, and stable puromycin-resistant (1 μg/ml) clones were selected. Transfections were carried out with LipofectAmine 2000 (Invitrogen, Carlsbad, CA), according to the manufacturer's protocol.</ce:para>
                        <ce:para id="p0240" view="all">STAT1 signaling was induced by exposing HeLa/STAT1-Luc cells to IFN-γ and monitored using luciferase activity.</ce:para>
                        <ce:para id="p0245" view="all">As previously described in the work of Bedel R. et al. <ce:cross-ref refid="bib17" id="crosref0470">[17]</ce:cross-ref> transfection of Stat3C expression vector or mock vector into MDA-MB-231 cells was carried out using lipofectamine 2000, followed by selection in medium supplemented with 1 μg/ml puromycin (Sigma, France).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.3" view="all">
                        <ce:label>4.3.3</ce:label>
                        <ce:section-title id="sectitle0140">STAT promoter assays</ce:section-title>
                        <ce:para id="p0250" view="all">To identify STAT3 inhibitor, biochemical compounds were assessed for their ability to interfere with STAT3 and/or STAT1 signaling using the STAT3-luc or STAT1-luc HeLa cells treated with oncostatin M or IFN-γ respectively. For that purpose, cells were seeded in a 24-well plate and incubated overnight in humidified incubator at 37 °C with 5% CO<ce:inf loc="post">2</ce:inf>. Cells were treated with vehicle or inhibitors at 50 μM for 1 h 100 ng/ml of Oncostatin M (Peprotech, France) or 20 ng/mL of IFN-γ (Peprotech, France) were added in culture medium for 6 h. Then, medium was removed by aspiration and 150 μL of lysis buffer (Promega, Madison, USA) was added to each well before a further incubation at room temperature and with constant shaking. Finally, 50 μL of each lysate were transferred into a new white 96-well plate for luciferase assay. To induce luciferase activity, 50 μL of luciferase substrate (Promega) was added. The plate was immediately read using a luminometer (Delphia Perkin Elmer, Waltham, MA, USA).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.4" view="all">
                        <ce:label>4.3.4</ce:label>
                        <ce:section-title id="sectitle0145">Fluorescence polarization assay</ce:section-title>
                        <ce:para id="p0255" view="all">Fluorescence polarization (FP) assay was conducted based on fluorescence signal differences between free and STAT3-bound fluorescently labeled peptide as described by Schust and Berg <ce:cross-ref refid="bib22" id="crosref0475">[22]</ce:cross-ref>. Briefly, all reactions contained 10 nM of the fluorescent peptide 5-FAM –G(pTyr) LPQTV-CONH2 (Genscript, Piscataway, NJ, USA) and 100 nM GST-tagged, full-length human STAT3 protein (SignalChem, Richmond, BC,Canada) in 96-well black plates (Perkin Elmer). For STAT1, we used the fluorescent peptide 5-FAM-G(pTyr)YIKTE- CONH2 (Genscript, Piscataway, NJ, USA)and the GST-tagged human STAT1b protein (SignalChem, Richmond, BC,Canada).</ce:para>
                        <ce:para id="p0260" view="all">For evaluating compounds, STAT3 or STAT1 protein was incubated with various concentrations of <ce:bold>23</ce:bold> or vehicle at room temperature for 60 min in the assay buffer (50 mM NaCl, 10 mM Hepes, pH 7.5, 1 mM EDTA, 0.01% Triton-X100, 2 mM dithiothreitol). Fluorescent peptide was added at a final concentration of 10 nM and incubated for 30 min at room temperature following which the FP measurements were examined by Envision 2102 Multilabel Reader (Perkin Elmer, Waltham, MA, USA) using FITC FP Dual module with excitation filter of FITC FP 480 and emission filter of FITC FP P-pol535 and S-pol535.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.5" view="all">
                        <ce:label>4.3.5</ce:label>
                        <ce:section-title id="sectitle0150">Western blotting</ce:section-title>
                        <ce:para id="p0265" view="all">Cells were lysed in RIPA buffer with antiproteases cocktail (complete Mini EDTA-free; Roche, France), then sonicated in ice. After BCA protein assay quantification, cells extracts were fractioned by SDS-PAGE. The proteins were then transferred on PVDF membranes that were blocked with 5% non-fat milk in Tris Buffer Saline with 0.1% Tween-20 (TBST) buffer for 90 min at room temperature. Membranes were incubated overnight at 4 °C with primary antibodies at dilution 1:1000 human anti-p-Tyr-STAT3 (pTyr705) (3E2) and anti-STAT3 (79D7), anti-p-Tyr-STAT1 (pTyr701) (58D6), anti-STAT1 (9H2), lamin B1, histone H1 (#9138, #4904, #9167, #9176, Cell signaling, Massachusetts, USA). β-actin, 1: 10<ce:sup loc="post">6</ce:sup> was used as an internal standard for loading. Immunodetection was carried out by using horseradish peroxidase-conjugated anti-rabbit IgG or anti-mouse IgG as a secondary antibody and enhanced chemiluminescence detection reagents. Chemiluminescence was detected using a camera and Bio-1D software (Wilber–Lourmat, France).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.6" view="all">
                        <ce:label>4.3.6</ce:label>
                        <ce:section-title id="sectitle0155">Confocal microscopy</ce:section-title>
                        <ce:para id="p0270" view="all">HeLa cells were cultured on poly-<ce:small-caps>l</ce:small-caps>-lysine coated glass slides (Sigma) and incubated overnight at 37 °C. Vehicle or inhibitors were incubated during 2 h at 37 °C. Cells were fixed in 3.7% formaldehyde and permeabilized with 0.1% Triton X- 100 for 15 min and further washed 3 times with PBS. After 20 min of blocking in 20% foetal bovine serum (FBS) and washing, cells were stained with the appropriate mAbs or an isotype-matched control antibody in phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA) for 2 h at room temperature. Afterwards, slides were washed and incubated with the appropriate secondary antibodies for 1 h at room temperature. Cells were then washed with PBS and labeled with DAPI and covered with cover slides with Dako fluorescent mounting medium (Dako, France). Confocal images were collected with an Olympus FV1000 laser scanning confocal microscope (Olympus, Center Valley, PA, USA).</ce:para>
                        <ce:para id="p0275" view="all">Antibodies used were anti-p-Tyr-STAT3 (pTyr705) (3E2) and anti-STAT3 (79D7). DAPI was used for nuclear staining (Molecular Probes).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.7" view="all">
                        <ce:label>4.3.7</ce:label>
                        <ce:section-title id="sectitle0160">In vitro differentiation of T cells</ce:section-title>
                        <ce:para id="p0280" view="all">Naïve CD4 T cells (CD4<ce:sup loc="post">+</ce:sup> CD62L<ce:sup loc="post">+</ce:sup>) were obtained from spleens of C57BL/6 mice by magnetic selection (CD4<ce:hsp sp="0.2"/></ce:hsp>+<ce:hsp sp="0.2"/></ce:hsp>CD62L + T Cell Isolation Kit II, mouse Miltenyi Biotec) according to the manufacturer's recommendations.</ce:para>
                        <ce:para id="p0285" view="all">Isolated naïve CD4<ce:sup loc="post">+</ce:sup> T cell were stimulated with plate-bound anti-CD3 (2 μg/mL; 145-2C11; BioXcell) and anti-CD28 (2 μg/mL; PV-1; BioXcell) and were polarized into effector CD4<ce:sup loc="post">+</ce:sup> T lymphocytes subsets without cytokines (Th0 cells) or with IL-12 (10 ng/mL), anti-IL-4 (10 μg/mL) (Th1 cells) or with TGF-β1 (2 ng/mL), IL-6 (30 ng/mL) anti–IFN–γ (10 μg/mL), anti-IL-4 (10 μg/mL) (Th17) or with TGF-β1 (5 ng/mL), IL-2 (20 ng/mL) anti–IFN–γ (10 μg/mL) (Treg).</ce:para>
                        <ce:para id="p0290" view="all">After 2 days of polarization, the cells were collected for real-time quantitative PCR analysis.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.8" view="all">
                        <ce:label>4.3.8</ce:label>
                        <ce:section-title id="sectitle0165">Real-time quantitative PCR</ce:section-title>
                        <ce:para id="p0295" view="all">Total RNA from T cells was extracted with RNeasy mini-kit (Qiagen). Reverse-transcription was performed using High Capacity RNA-to-cDNA polymerase (Life Technologies) and was analyzed by the Taqman method (Applied Biosystems) with the CFX-96 real-time PCR system, according to the manufacturer's instructions (Biorad). Expression of target RNA was normalized to mouse GAPDH. Primers used were: RORc (Mm00441139_m1), Foxp3 (Mm00475156_m1) and T-bet (Mm00450960_m1).</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.9" view="all">
                        <ce:label>4.3.9</ce:label>
                        <ce:section-title id="sectitle0170">Cell line proliferation assays</ce:section-title>
                        <ce:para id="p0300" view="all">MTT assay was performed to determine the effects of compound <ce:bold>23</ce:bold> on cell proliferation. Briefly, MDA-MB-231 and MDA-MB-231 STAT3C or B9 cell line were plated in a 96 well tissue culture plate (10,000 cells per well) and incubated for 24 h. After incubation the cells were treated with vehicle or <ce:bold>23</ce:bold> (50 μM final concentration) for 72 h. After incubation, freshly prepared MTT (5 mg/ml) in PBS was added to each well and incubated for 3 h and the plate was read at 570 nm by Envision 2102 Multilabel Reader.</ce:para>
                     </ce:section>
                     <ce:section id="sec4.3.10" view="all">
                        <ce:label>4.3.10</ce:label>
                        <ce:section-title id="sectitle0175">Assessment of cytokine production</ce:section-title>
                        <ce:para id="p0305" view="all">For this purpose, human peripheral blood lymphocytes were cultured during 1 day with IL-2 (1000UI/mL), or with the tumor cell line (HT-29 and MDA-MB-231). After 24 h, cell culture supernatants were assayed by ELISA for human IFN-γ (Diaclone, France) according to the manufacturer's protocol.</ce:para>
                     </ce:section>
                  </ce:section>
               </ce:section>
            </ce:sections>
            <ce:acknowledgment id="ack0010" view="all">
               <ce:section-title id="sectitle0180">Acknowledgment</ce:section-title>
               <ce:para id="p0310" view="all">We thank Dr C. K. Glass (Department of Medicine, University of California, San Diego, CA, U.S.A.) for the STAT1 reporter 8x-GAS-Luc plasmid. The authors are thankful to the <ce:grant-sponsor id="gs1" xlink:type="simple" xlink:role="http://www.elsevier.com/xml/linking-roles/grant-sponsor">conseil régional de Franche Comté</ce:grant-sponsor> support grant <ce:grant-number refid="gs1">2012-0167</ce:grant-number>, and to the Supercomputing Center of the IN2P3-CNRS (Villeurbanne, France) for the allocation of computing time.</ce:para>
            </ce:acknowledgment>
            <ce:appendices view="all">
               <ce:section id="appsec1" view="extended">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0185">Supplementary data</ce:section-title>
                  <ce:para id="p0315" view="all">The following is the supplementary data related to this article:<ce:display>
                        <ce:e-component id="ec1">
                           <ce:link locator="mmc1"/></ce:link>
                        </ce:e-component>
                     </ce:display>
                  </ce:para>
               </ce:section>
               <ce:section id="appsec2" view="compact-standard">
                  <ce:label>Appendix A</ce:label>
                  <ce:section-title id="sectitle0190">Supplementary data</ce:section-title>
                  <ce:para id="p0320" view="all">Supplementary data related to this article can be found at <ce:inter-ref xlink:href="doi:10.1016/j.ejmech.2015.08.054" id="intref0010" xlink:type="simple">http://dx.doi.org/10.1016/j.ejmech.2015.08.054</ce:inter-ref>.</ce:para>
               </ce:section>
            </ce:appendices>
         </body>
         <tail view="all">
            <ce:bibliography id="cebib0010" view="all">
               <ce:section-title id="sectitle0195">References</ce:section-title>
               <ce:bibliography-sec id="cebibsec0010" view="all">
                  <ce:bib-reference id="bib1">
                     <ce:label>[1]</ce:label>
                     <sb:reference id="bib1a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Transcription factors as targets for cancer therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>2</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>740</sb:first-page>
                              <sb:last-page>749</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/nrc906</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib1b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STATs and gene regulation</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>277</sb:volume-nr>
                              </sb:series>
                              <sb:date>1997</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1630</sb:first-page>
                              <sb:last-page>1635</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1126/science.277.5332.1630</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib2">
                     <ce:label>[2]</ce:label>
                     <sb:reference id="bib2a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.C.</ce:given-name>
                                 <ce:surname>Greenlund</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Farrar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.L.</ce:given-name>
                                 <ce:surname>Viviano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.D.</ce:given-name>
                                 <ce:surname>Schreiber</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>EMBO J.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>7</sb:issue-nr>
                              <sb:date>1994</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1591</sb:first-page>
                              <sb:last-page>1600</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib2b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Shuai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.R.</ce:given-name>
                                 <ce:surname>Stark</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.M.</ce:given-name>
                                 <ce:surname>Kerr</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>261</sb:volume-nr>
                              </sb:series>
                              <sb:date>1993</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1744</sb:first-page>
                              <sb:last-page>1746</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1126/science.7690989</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib3">
                     <ce:label>[3]</ce:label>
                     <sb:reference id="bib3a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.N.</ce:given-name>
                                 <ce:surname>Ihle</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STATs: signal transducers and activators of transcription</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cell</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>84</sb:volume-nr>
                              </sb:series>
                              <sb:date>1996</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>331</sb:first-page>
                              <sb:last-page>334</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib3b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.H.</ce:given-name>
                                 <ce:surname>Heim</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The Jak-Stat pathway: cytokine signaling from the receptor to the nucleus</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Recept. Signal. Transduct. Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>1999</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>75</sb:first-page>
                              <sb:last-page>120</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.3109/10799899909036638</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib4">
                     <ce:label>[4]</ce:label>
                     <sb:reference id="sref1">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>The STATs of cancer - new molecular targets come of age</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Cancer</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>4</sb:volume-nr>
                              </sb:series>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>97</sb:first-page>
                              <sb:last-page>105</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/nrc1275</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib5">
                     <ce:label>[5]</ce:label>
                     <sb:reference id="sref2">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Pensa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Regis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Boselli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Novelli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.</ce:given-name>
                                 <ce:surname>Poli</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT1 and STAT3 in tumorigenesis: two sides of the same coin?</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:edited-book>
                              <sb:editors>
                                 <sb:editor>
                                    <ce:given-name>A.</ce:given-name>
                                    <ce:surname>Stephanou</ce:surname>
                                 </sb:editor>
                              </sb:editors>
                              <sb:title>
                                 <sb:maintitle>JAK-STAT Pathway in Disease</sb:maintitle>
                              </sb:title>
                              <sb:date>2008</sb:date>
                              <sb:publisher>
                                 <sb:name>Landes Bioscience</sb:name>
                                 <sb:location>Austin</sb:location>
                              </sb:publisher>
                           </sb:edited-book>
                           <sb:pages>
                              <sb:first-page>100</sb:first-page>
                              <sb:last-page>121</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib6">
                     <ce:label>[6]</ce:label>
                     <sb:reference id="sref3">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Amadi-Obi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.R.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.M.</ce:given-name>
                                 <ce:surname>Mahdi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.L.</ce:given-name>
                                 <ce:surname>Clarke</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.B.</ce:given-name>
                                 <ce:surname>Nussenblatt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.</ce:given-name>
                                 <ce:surname>Gery</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.S.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.E.</ce:given-name>
                                 <ce:surname>Egwuagu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Med.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>6</sb:issue-nr>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>711</sb:first-page>
                              <sb:last-page>718</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/nm1585</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib7">
                     <ce:label>[7]</ce:label>
                     <sb:reference id="sref4">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Costantino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Barlocco</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT3 as a target for cancer drug discovery</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>15</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>834</sb:first-page>
                              <sb:last-page>843</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.2174/092986708783955464</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib8">
                     <ce:label>[8]</ce:label>
                     <sb:reference id="bib8a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.K.</ce:given-name>
                                 <ce:surname>Mankan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.R.</ce:given-name>
                                 <ce:surname>Greten</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Expert Opin. Invest. Drugs</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>20</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1263</sb:first-page>
                              <sb:last-page>1275</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1517/13543784.2011.601739</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib8b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Lavecchia</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Di Giovanni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Novellino</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT-3 Inhibitors: state of the art and new horizons for cancer treatment</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Curr. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2359</sb:first-page>
                              <sb:last-page>2375</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.2174/092986711795843218</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib8c">
                        <ce:label>c)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.D.</ce:given-name>
                                 <ce:surname>Page</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.P.</ce:given-name>
                                 <ce:surname>Ball</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Signal transducer and activator of transcription 3 inhibitors: a patent review</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Expert Opin. Ther. Pat.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>21</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>1</sb:issue-nr>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>65</sb:first-page>
                              <sb:last-page>83</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1517/13543776.2011.539205</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib9">
                     <ce:label>[9]</ce:label>
                     <sb:reference id="sref6">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Debnath</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Neamati</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>55</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>15</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6645</sb:first-page>
                              <sb:last-page>6668</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm300207s</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib10">
                     <ce:label>[10]</ce:label>
                     <ce:other-ref id="sref7">
                        <ce:textref>
                           <ce:inter-ref xlink:href="http://bioinfo-pharma.u-strasbg.fr/bioinfo" id="intref0015" xlink:type="simple">http://bioinfo-pharma.u-strasbg.fr/bioinfo</ce:inter-ref>.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib11">
                     <ce:label>[11]</ce:label>
                     <sb:reference id="sref8">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Becker</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Groner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.W.</ce:given-name>
                                 <ce:surname>Muller</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Three-dimensional structure of the Stat3beta homodimer bound to DNA</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nature</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>394</sb:volume-nr>
                              </sb:series>
                              <sb:date>1998</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>145</sb:first-page>
                              <sb:last-page>151</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/28101</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib12">
                     <ce:label>[12]</ce:label>
                     <sb:reference id="sref9">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Marcou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Rognan</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Optimizing fragment and scaffold docking by use of molmecular interaction fingeprints</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Chem. Inf. Model</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>47</sb:volume-nr>
                              </sb:series>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>195</sb:first-page>
                              <sb:last-page>207</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/ci600342e</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib13">
                     <ce:label>[13]</ce:label>
                     <sb:reference id="sref10">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Buettner</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Corzano</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Rashid</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Senthil</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Hedvat</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Schroeder</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Mao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Herrmann</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Yim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.C.</ce:given-name>
                                 <ce:surname>Yuan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Yakushijin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Yakushijin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Vaidehi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Moore</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Gugiu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.D.</ce:given-name>
                                 <ce:surname>Lee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Yip</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Horne</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.C.</ce:given-name>
                                 <ce:surname>Williams</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Chem. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>5</sb:issue-nr>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>432</sb:first-page>
                              <sb:last-page>443</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/cb100253e</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib14">
                     <ce:label>[14]</ce:label>
                     <sb:reference id="sref11">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Klampfer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.A.</ce:given-name>
                                 <ce:surname>Swaby</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Augenlicht</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Requirement of histone deacetylase activity for signaling by STAT1</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Biol. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>279</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>29</sb:issue-nr>
                              <sb:date>2004</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>30358</sb:first-page>
                              <sb:last-page>30368</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1074/jbc.M401359200</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib15">
                     <ce:label>[15]</ce:label>
                     <sb:reference id="sref12">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Song</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>102</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>13</sb:issue-nr>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4700</sb:first-page>
                              <sb:last-page>4705</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1073/pnas.0409894102</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib16">
                     <ce:label>[16]</ce:label>
                     <sb:reference id="sref13">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Niu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.L.</ce:given-name>
                                 <ce:surname>Wright</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Song</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Haura</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Wang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Sinibaldi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Coppola</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Heller</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.M.</ce:given-name>
                                 <ce:surname>Ellis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Karras</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Bromberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Pardoll</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>21</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>13</sb:issue-nr>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2000</sb:first-page>
                              <sb:last-page>2008</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/sj/onc/1205260</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib17">
                     <ce:label>[17]</ce:label>
                     <sb:reference id="sref14">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Bedel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Thiery-Vuillemin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Grandclement</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Balland</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.P.</ce:given-name>
                                 <ce:surname>Remy-Martin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Kantelip</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.R.</ce:given-name>
                                 <ce:surname>Pallandre</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Pivot</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ferrand</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Tiberghien</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Borg</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cancer Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>71</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>5</sb:issue-nr>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1615</sb:first-page>
                              <sb:last-page>1626</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1158/0008-5472</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib18">
                     <ce:label>[18]</ce:label>
                     <sb:reference id="sref15">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.E.</ce:given-name>
                                 <ce:surname>Egwuagu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT3 in CD4<ce:sup loc="post">+</ce:sup> T helper cell differentiation and inflammatory diseases</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Cytokine</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>47</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>3</sb:issue-nr>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>149</sb:first-page>
                              <sb:last-page>156</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.cyto.2009.07.003</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib19">
                     <ce:label>[19]</ce:label>
                     <sb:reference id="sref16">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Bhasin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Cisek</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Pandharkar</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Regan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Pandit</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.-K.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Design, synthesis, and studies of small molecule STAT3 inhibitors</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>391</sb:first-page>
                              <sb:last-page>395</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.bmcl.2007.10.031</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib20">
                     <ce:label>[20]</ce:label>
                     <sb:reference id="sref17">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Ren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Duan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>He</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Wu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Pan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Pei</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>454</sb:first-page>
                              <sb:last-page>459</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/ml100146z</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib21">
                     <ce:label>[21]</ce:label>
                     <sb:reference id="sref18">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Yang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Chu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Terry</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Q.</ce:given-name>
                                 <ce:surname>Shen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhou</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>498</sb:first-page>
                              <sb:last-page>507</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.ejmech.2013.01.023</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib22">
                     <ce:label>[22]</ce:label>
                     <sb:reference id="sref19">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Schust</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Sperl</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Hollis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.U.</ce:given-name>
                                 <ce:surname>Mayer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Berg</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Stattic: a small-molecule inhibitor of STAT3 activation and dimerization</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Chem. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>13</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1235</sb:first-page>
                              <sb:last-page>1242</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.chembiol.2006.09.018</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib23">
                     <ce:label>[23]</ce:label>
                     <sb:reference id="sref20">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Liu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Jou</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3)</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>54</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5592</sb:first-page>
                              <sb:last-page>5596</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm101330h</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib24">
                     <ce:label>[24]</ce:label>
                     <sb:reference id="sref21">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.M.</ce:given-name>
                                 <ce:surname>Shahani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Haftchenary</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Lukkarila</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Ball</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Nona</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of purine-scaffold small-molecule inhibitors of Stat3 activation by QSAR Studies</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>2</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>79</sb:first-page>
                              <sb:last-page>84</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/ml100224d</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib25">
                     <ce:label>[25]</ce:label>
                     <sb:reference id="sref22">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Matsuno</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Masuda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Uehara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Sato</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Muroya</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Takahashi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Yokotagawa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Furuya</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Okawara</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Otsuka</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ogo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Ashizawa</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Oshita</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Tai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Ishii</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Akiyama</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Asai</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of a new series of STAT3 inhibitors by virtual screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>1</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>371</sb:first-page>
                              <sb:last-page>375</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/ml1000273</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib26">
                     <ce:label>[26]</ce:label>
                     <sb:reference id="sref23">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Saturnino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Palladino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Napoli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.S.</ce:given-name>
                                 <ce:surname>Sinicropi</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Botta</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Sala</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Carcereri de Prati</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Novellino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Suzuki</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis and biological evaluation of new N-alkylcarbazole derivatives as STAT3 inhibitors: preliminary study</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>60</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>112</sb:first-page>
                              <sb:last-page>119</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.ejmech.2012.11.004</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib27">
                     <ce:label>[27]</ce:label>
                     <sb:reference id="sref24">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Yu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Xiao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Lin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>56</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4402</sb:first-page>
                              <sb:last-page>4412</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm400080c</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib28">
                     <ce:label>[28]</ce:label>
                     <sb:reference id="sref25">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.C.</ce:given-name>
                                 <ce:surname>Cole</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.-P.B.</ce:given-name>
                                 <ce:surname>Chang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Ayyad</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Asselin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Hao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Gibbons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.A.</ce:given-name>
                                 <ce:surname>Jelinsky</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.A.</ce:given-name>
                                 <ce:surname>Saraf</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Park</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>51</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4115</sb:first-page>
                              <sb:last-page>4121</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm701271y</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib29">
                     <ce:label>[29]</ce:label>
                     <sb:reference id="sref26">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of novel inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Eur. J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>62</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>301</sb:first-page>
                              <sb:last-page>310</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.ejmech.2013.01.009</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib30">
                     <ce:label>[30]</ce:label>
                     <sb:reference id="sref27">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.</ce:given-name>
                                 <ce:surname>Ding</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>23</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2225</sb:first-page>
                              <sb:last-page>2229</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.bmcl.2013.01.056</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib31">
                     <ce:label>[31]</ce:label>
                     <sb:reference id="sref28">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Siddiquee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.C.</ce:given-name>
                                 <ce:surname>Guida</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Blaskovich</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.</ce:given-name>
                                 <ce:surname>Greedy</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.R.</ce:given-name>
                                 <ce:surname>Lawrence</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.L.R.</ce:given-name>
                                 <ce:surname>Yip</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.M.</ce:given-name>
                                 <ce:surname>McLaughlin</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>N.J.</ce:given-name>
                                 <ce:surname>Lawrence</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Sebti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>104</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>18</sb:issue-nr>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>7391</sb:first-page>
                              <sb:last-page>7396</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1073/pnas.0609757104</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib32">
                     <ce:label>[32]</ce:label>
                     <sb:reference id="bib32a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fletcher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.D.G.</ce:given-name>
                                 <ce:surname>Page</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.H.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sharmeen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Singh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Schimmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Trudel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Antagonism of the Stat3–Stat3 protein dimer with salicylic acid based small molecules</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ChemMedChem</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1459</sb:first-page>
                              <sb:last-page>1470</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1002/cmdc.201100194</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib32b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.D.G.</ce:given-name>
                                 <ce:surname>Page</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fletcher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sharmeen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Datti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.L.</ce:given-name>
                                 <ce:surname>Wrana</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Trudel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Schimmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>21</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>5605</sb:first-page>
                              <sb:last-page>5609</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.bmcl.2011.06.056</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib32c">
                        <ce:label>c)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fletcher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>A novel small-molecule disrupts Stat3 SH2 domainphosphotyrosine interactions and Stat3-dependent tumor processes</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Biochem. Pharmacol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>79</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1398</sb:first-page>
                              <sb:last-page>1409</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.bcp.2010.01.001</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib32d">
                        <ce:label>d)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fletcher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Singh</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.D.G.</ce:given-name>
                                 <ce:surname>Page</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sharmeen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.M.</ce:given-name>
                                 <ce:surname>Shahani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Schimmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Disruption of transcriptionally active stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ChemBioChem</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>10</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1959</sb:first-page>
                              <sb:last-page>1964</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1002/cbic.200900172</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib32e">
                        <ce:label>e)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Hao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Hu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Niu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.-P.B.</ce:given-name>
                                 <ce:surname>Chang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Gibbons</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Xu</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>18</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>4988</sb:first-page>
                              <sb:last-page>4992</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.bmcl.2008.08.032</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib33">
                     <ce:label>[33]</ce:label>
                     <sb:reference id="bib33a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>B.D.G.</ce:given-name>
                                 <ce:surname>Page</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.T.</ce:given-name>
                                 <ce:surname>Namanja</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.</ce:given-name>
                                 <ce:surname>Paladino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>109</sb:volume-nr>
                              </sb:series>
                              <sb:issue-nr>24</sb:issue-nr>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>9623</sb:first-page>
                              <sb:last-page>9628</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1073/pnas.1121606109</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib33b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>B.D.G.</ce:given-name>
                                 <ce:surname>Page</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.C.</ce:given-name>
                                 <ce:surname>Croucher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.H.</ce:given-name>
                                 <ce:surname>Li</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Haftchenary</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.H.</ce:given-name>
                                 <ce:surname>Jimenez-Zepeda</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Atkinson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.A.</ce:given-name>
                                 <ce:surname>Spagnuolo</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Y.L.</ce:given-name>
                                 <ce:surname>Wong</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Colaguori</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.M.</ce:given-name>
                                 <ce:surname>Lewis</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Schimmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Trudel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>56</sb:volume-nr>
                              </sb:series>
                              <sb:date>2013</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>7190</sb:first-page>
                              <sb:last-page>7200</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm3017255</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib34">
                     <ce:label>[34]</ce:label>
                     <sb:reference id="bib34a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.P.</ce:given-name>
                                 <ce:surname>Glenn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.A.</ce:given-name>
                                 <ce:surname>Siddiquee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.P.</ce:given-name>
                                 <ce:surname>Katt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>E.</ce:given-name>
                                 <ce:surname>Masson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Sebti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Hamilton</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Targeting protein-protein interactions: suppression of Stat3 dimerization with rationally designed small-molecule, nonpeptidic SH2 domain binders</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ChemBioChem</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>9</sb:volume-nr>
                              </sb:series>
                              <sb:date>2008</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2800</sb:first-page>
                              <sb:last-page>2803</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1002/cbic.200800291</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib34b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.A.Z.</ce:given-name>
                                 <ce:surname>Siddiquee</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Glen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.P.</ce:given-name>
                                 <ce:surname>Katt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Schroeck</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Sebti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Hamilton</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>ACS Chem. Biol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>2</sb:volume-nr>
                              </sb:series>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>787</sb:first-page>
                              <sb:last-page>798</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/cb7001973</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib34c">
                        <ce:label>c)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.K.</ce:given-name>
                                 <ce:surname>Mandai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.S.</ce:given-name>
                                 <ce:surname>Lião</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>McMurray</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Synthesis of phosphatase-stable, cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Org. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>11</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>3394</sb:first-page>
                              <sb:last-page>3397</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/ol9012662</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib34d">
                        <ce:label>d)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>D.R.I.V.</ce:given-name>
                                 <ce:surname>Coleman</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Ren</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.K.</ce:given-name>
                                 <ce:surname>Mandal</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.G.</ce:given-name>
                                 <ce:surname>Cameron</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.A.</ce:given-name>
                                 <ce:surname>Dyer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Muranjan</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Campbell</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Chen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>McMurray</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Investigation of the binding determinants of phosphopeptides targeted to the Src homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>48</sb:volume-nr>
                              </sb:series>
                              <sb:date>2005</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>6661</sb:first-page>
                              <sb:last-page>6670</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/jm050513m</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib34e">
                        <ce:label>e)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>V.M.</ce:given-name>
                                 <ce:surname>Shahani</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.</ce:given-name>
                                 <ce:surname>Yue</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Fletcher</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Sharmeen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.A.</ce:given-name>
                                 <ce:surname>Sukhai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>D.P.</ce:given-name>
                                 <ce:surname>Luu</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>X.</ce:given-name>
                                 <ce:surname>Zhang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>H.</ce:given-name>
                                 <ce:surname>Sun</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.</ce:given-name>
                                 <ce:surname>Zhao</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Schimmer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>19</sb:volume-nr>
                              </sb:series>
                              <sb:date>2011</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1823</sb:first-page>
                              <sb:last-page>1838</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.bmc.2010.12.010</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib34f">
                        <ce:label>f)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>P.T.</ce:given-name>
                                 <ce:surname>Gunning</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>W.P.</ce:given-name>
                                 <ce:surname>Katt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Glenn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Siddique</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.S.</ce:given-name>
                                 <ce:surname>Kim</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.</ce:given-name>
                                 <ce:surname>Jove</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.M.</ce:given-name>
                                 <ce:surname>Sebti</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.</ce:given-name>
                                 <ce:surname>Turkson</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.D.</ce:given-name>
                                 <ce:surname>Hamilton</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Bioorg. Med. Chem. Lett.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>17</sb:volume-nr>
                              </sb:series>
                              <sb:date>2007</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1875</sb:first-page>
                              <sb:last-page>1878</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1016/j.bmcl.2007.01.077</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib35">
                     <ce:label>[35]</ce:label>
                     <sb:reference id="bib35a">
                        <ce:label>a)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Shuai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Schindler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.R.</ce:given-name>
                                 <ce:surname>Prezioso</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Activation of transcription by IFN-gamma:tyrosine phosphorylation of a91-kD DNA binding protein</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>258</sb:volume-nr>
                              </sb:series>
                              <sb:date>1992</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1808</sb:first-page>
                              <sb:last-page>1812</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1126/science.1281555</ce:doi>
                        </sb:host>
                     </sb:reference>
                     <sb:reference id="bib35b">
                        <ce:label>b)</ce:label>
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>C.</ce:given-name>
                                 <ce:surname>Schindler</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Shuai</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>V.R.</ce:given-name>
                                 <ce:surname>Prezioso</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Interferon-dependenttyrosine phosphorylationofalatentcytoplasmictranscriptionfactor</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Science</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>257</sb:volume-nr>
                              </sb:series>
                              <sb:date>1992</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>809</sb:first-page>
                              <sb:last-page>813</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1126/science.1496401</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib36">
                     <ce:label>[36]</ce:label>
                     <sb:reference id="sref29">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>J.F.</ce:given-name>
                                 <ce:surname>Bromberg</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.M.</ce:given-name>
                                 <ce:surname>Horvath</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>Z.</ce:given-name>
                                 <ce:surname>Wen</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.D.</ce:given-name>
                                 <ce:surname>Schreiber</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>J.E.</ce:given-name>
                                 <ce:surname>Darnell</ce:surname>
                                 <ce:suffix>Jr.</ce:suffix>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Transcriptionally active Stat1 is required for the antiproliferative effects of both inter- feron alpha and interferon gamma</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Proc. Natl. Acad. Sci. U. S. A.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>93</sb:volume-nr>
                              </sb:series>
                              <sb:date>1996</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>7673</sb:first-page>
                              <sb:last-page>7678</sb:last-page>
                           </sb:pages>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib37">
                     <ce:label>[37]</ce:label>
                     <sb:reference id="sref30">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>G.P.</ce:given-name>
                                 <ce:surname>Dunn</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.M.</ce:given-name>
                                 <ce:surname>Koebel</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>R.D.</ce:given-name>
                                 <ce:surname>Schreiber</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Interferons, immunity and cancer immunoediting</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nat. Rev. Immunol.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>6</sb:volume-nr>
                              </sb:series>
                              <sb:date>2006</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>836</sb:first-page>
                              <sb:last-page>848</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/nri1961</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib38">
                     <ce:label>[38]</ce:label>
                     <sb:reference id="sref31">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Huang</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>C.D.</ce:given-name>
                                 <ce:surname>Bucana</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Van Arsdall</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>I.J.</ce:given-name>
                                 <ce:surname>Fidler</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>STAT1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Oncogene</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>21</sb:volume-nr>
                              </sb:series>
                              <sb:date>2002</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>2504</sb:first-page>
                              <sb:last-page>2512</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1038/sj/onc/1205341</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib39">
                     <ce:label>[39]</ce:label>
                     <ce:other-ref id="sref32">
                        <ce:textref>Pipeline Pilot, version 7.5, Accelrys, San Diego, CA 92121, USA.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib40">
                     <ce:label>[40]</ce:label>
                     <ce:other-ref id="sref33">
                        <ce:textref>Filter, version 2., OpenEye Scientific Software, Santa Fe, NM 87508, USA.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib41">
                     <ce:label>[41]</ce:label>
                     <ce:other-ref id="sref34">
                        <ce:textref>Chemaxon Kft, 1031 Budapest, Hungary.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib42">
                     <ce:label>[42]</ce:label>
                     <ce:other-ref id="sref35">
                        <ce:textref>SYBYL, version 8.0, Tripos, St.Louis, MO 63101, USA.</ce:textref>
                     </ce:other-ref>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib43">
                     <ce:label>[43]</ce:label>
                     <sb:reference id="sref36">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Korb</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Stützle</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.E.</ce:given-name>
                                 <ce:surname>Exner</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Empirical scoring functions for advanced protein-ligand docking with PLANTS</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Chem. Inf. Model.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>49</sb:volume-nr>
                              </sb:series>
                              <sb:date>2009</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>84</sb:first-page>
                              <sb:last-page>96</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1021/ci800298z</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib44">
                     <ce:label>[44]</ce:label>
                     <sb:reference id="sref37">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Biasini</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>S.</ce:given-name>
                                 <ce:surname>Bienert</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.</ce:given-name>
                                 <ce:surname>Waterhouse</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>K.</ce:given-name>
                                 <ce:surname>Arnold</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>G.</ce:given-name>
                                 <ce:surname>Studer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Schmidt</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>F.</ce:given-name>
                                 <ce:surname>Kiefer</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.G.</ce:given-name>
                                 <ce:surname>Cassarino</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>M.</ce:given-name>
                                 <ce:surname>Bertoni</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>L.</ce:given-name>
                                 <ce:surname>Bordoli</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>T.</ce:given-name>
                                 <ce:surname>Schwede</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>Nucleic Acids Res.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>42</sb:volume-nr>
                              </sb:series>
                              <sb:date>2014</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>252</sb:first-page>
                              <sb:last-page>258</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1093/nar/gku340</ce:doi>
                        </sb:host>
                        <sb:comment>(Online)</sb:comment>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib45">
                     <ce:label>[45]</ce:label>
                     <sb:reference id="sref38">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>O.</ce:given-name>
                                 <ce:surname>Trott</ce:surname>
                              </sb:author>
                              <sb:author>
                                 <ce:given-name>A.J.</ce:given-name>
                                 <ce:surname>Olson</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Comput. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>31</sb:volume-nr>
                              </sb:series>
                              <sb:date>2010</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>455</sb:first-page>
                              <sb:last-page>461</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1002/jcc.21334</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
                  <ce:bib-reference id="bib46">
                     <ce:label>[46]</ce:label>
                     <sb:reference id="sref39">
                        <sb:contribution langtype="en">
                           <sb:authors>
                              <sb:author>
                                 <ce:given-name>S.O.</ce:given-name>
                                 <ce:surname>Yesylevskyy</ce:surname>
                              </sb:author>
                           </sb:authors>
                           <sb:title>
                              <sb:maintitle>Pteros: fast and easy to use open-source C++ library for molecular analysis</sb:maintitle>
                           </sb:title>
                        </sb:contribution>
                        <sb:host>
                           <sb:issue>
                              <sb:series>
                                 <sb:title>
                                    <sb:maintitle>J. Comput. Chem.</sb:maintitle>
                                 </sb:title>
                                 <sb:volume-nr>33</sb:volume-nr>
                              </sb:series>
                              <sb:date>2012</sb:date>
                           </sb:issue>
                           <sb:pages>
                              <sb:first-page>1632</sb:first-page>
                              <sb:last-page>1636</sb:last-page>
                           </sb:pages>
                           <ce:doi>10.1002/jcc.22989</ce:doi>
                        </sb:host>
                     </sb:reference>
                  </ce:bib-reference>
               </ce:bibliography-sec>
            </ce:bibliography>
         </tail>
      </article>
   </xocs:serial-item></xocs:doc></originaltext></full-text-retrieval-response>